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Intraovarian growth factors play a vital role in influencing the fate of 
ovarian follicles. They affect proliferation versus apoptosis of granulosa cells 
(GCs), and can influence whether small antral follicles continue their growth or 
undergo atresia. Transforming Growth Factor-alpha (TGF), an oocyte-derived 
growth factor, is thought to regulate granulosa cell function, yet has been largely 
overshadowed by current interest in TGF-beta superfamily members, such as 
bone morphogenetic proteins (BMPs) and anti-Mullerian hormone (AMH). In the 
current study, effects of TGF on bovine GC proliferation, intracellular signaling 
and cytokine-induced apoptosis were evaluated. Briefly, all small antral follicles 
(3-5mm) from bovine ovaries were aspirated and the cells were initially plated in 
T25 flasks containing DMEM/F12 medium, 10% FBS, and antibiotic-
antimycotic, and incubated at 37 degrees Celsius in 5% CO2 for 3-4 days. Once 
confluent, the cells were sub-cultured to 96-, 12- or 6-well plates in serum-free 
conditions (insulin 100 ng/mL; transferrin 55 ng/mL; sodium selenite 6.7 pg/mL). 
24-hour treatment of bovine GCs with TGF (10 and 100ng/mL) stimulated cell 
proliferation compared to control (p<0.05; n = 7 ovary pairs). Cell proliferation 
was accompanied by a concomitant increase in mitogen-activated protein kinase 
(MAPK) signaling within 2 hours of treatment, as measured by phosphorylated 
ERK1/2 expression (p<0.05, n = 3 ovary pairs). These effects were entirely 
negated, however, by the MAPK inhibitor, U0126 (10uM, p<0.05). Additionally, 
pre-exposure of the bovine GCs to TGFα (100ng/mL) failed to prevent Fas 
Ligand (100ng/mL)-induced apoptosis, as determined by caspase 3/7 activity 
(P<0.05, n = 7 ovary pairs). Collectively, the results indicate TGF stimulates 
proliferation of bovine GCs from small antral follicles via a MAPK/ERK-
mediated mechanism, but this action alone fails to prevent apoptosis, suggesting 
TGF may be incapable of promoting the persistence of follicles during the 
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CHAPTER 1: REVIEW OF LITERATURE 
1.1 Bovine Folliculogenesis: Historical Perspectives and Understanding 
Bovine folliculogenesis is a physiological process during which ovarian follicles 
are recruited in cohorts and grow over the course of the estrous cycle. Each cohort 
initially grows synchronously, through the integration of systemic gonadotropins that 
initiate the responsiveness of intraovarian cell populations. Specifically, the actions of 
hypothalamic gonadotropin releasing hormone (GnRH) and its action on the anterior 
pituitary gland to stimulate the production of follicle stimulating hormone (FSH) and 
luteinizing hormone (LH) which have direct stimulatory effects on ovarian follicles. As 
its name suggests, FSH is responsible for stimulating follicular growth and recruiting 
primary follicle cohorts, which begin to grow synchronously and produce estradiol. 
Ultimately, these activities result in the selection of a dominant follicle from the cohort, 
which then potentially results in ovulation. With the advancement of ultrasonograpy and 
molecular techniques, our understanding of the bovine estrous cycle and folliculogenesis 
has accelerated immensely. Researchers can now visualize follicular wave patterns in 
animals non-invasively and in real-time, which has established the phases of follicular 
development, and has connected them to temporal changes in systemic gonadotropins. 
Molecular approaches have facilitated characterization of intraovarian mechanisms which 
respond to circulating gonadotropins. Collectively, these activities support local ovarian 
dynamics in and among the theca and granulosa cells (GCs) of the follicle, as well as the 
oocyte itself. Some of the major discoveries contributing to our current understanding of 
folliculogenesis in animals are highlighted in the following sections.    
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The estrous cycle of cattle has been very well characterized, including the 
behavioral, hormonal, and mechanistic aspects associated with ovarian function in cows 
and heifers [1]–[6]. In 1960, Erkki Rajakoski characterized the timing of follicular events 
in the bovine ovary in great detail through the use of comparative methods and 
slaughterhouse specimens [7]. Rajakoski concluded that primordial follicles develop into 
antral follicles and then Graafian follicles, and that their growth is influenced by the 
mitotic activity of GCs [7]. He also hypothesized the existence of two follicular waves 
during the estrous cycle, in which two dominant follicles develop (attaining a diameter of 
8-13mm), but the first dominant follicle of the first wave undergoes atresia and the 
second dominant follicle of the second wave ovulates [7]. The ovulated follicle forms the 
corpus luteum of the next estrous cycle, that then regresses around seventeen days post-
ovulation [7]. Thus, the two-wave hypothesis of follicular growth during folliculogenesis 
in cattle was conceived, and it had a profound effect that guided research in this area for 
many years to follow. For instance, 20 years later, in 1984, Pierson and Ginther published 
observations about bovine ovarian function in which ovarian structures within the cow 
were visualized using transrectal ultrasonography [8]. Although the study was primarily 
descriptive and did not test an experimental hypothesis, it transformed research in 
reproductive physiology by establishing transrectal ultrasonographic techniques to 
accurately image follicles within bovine ovaries and sequentially monitor them over the 
course of the entire estrous cycle [8]. Using this technique, the authors visualized follicles 
as small as 2-3mm, noting that follicles and corpora lutea have distinct echogenic patterns 
which make them easily distinguishable and identifiable [8]. The ultrasound data 
assimilated in this study also further supported the two-wave hypothesis because the 
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authors noticed that during each estrous cycle, an anovulatory midcycle dominant follicle 
is evident [8].  
The emergence of ultrasonography was a defining moment for this area of 
reproductive physiology research as many investigators began to appreciate the value of 
monitoring bovine ovarian follicular dynamics non-invasively and in real-time. 
Additionally, ultrasonography has utility to examine follicular dynamics during 
pregnancy without harming the fetus, which is something unattainable using 
slaughterhouse sample approaches [9]. The knowledge acquired using this tool facilitated 
targeted investigations of hypotheses regarding the specific pattern of follicular 
emergence and development; including the two wave hypothesis [7] and the hypothesis 
that follicular growth and atresia is a continuous process [10], [11]. In 1988, for example, 
it was discovered that two, three, and even four wave patterns of follicular development 
occur in cattle [12]–[14]. Additionally, these studies were among the first to show that 
growth rate of the largest (termed dominant) follicle does not differ among follicular 
waves, and that the ovulatory follicle is consistently the dominant follicle on the day of 
estrus (standing heat). Measurement of plasma progesterone and LH confirmed that these 
two hormones are associated with atresia and the onset of ovulation of the dominant 
follicle, respectively [12]. Sirois and Fortune [11] were among the first to track follicles 
individually over the course of an estrous cycle, and they reported that three- and even 
four-wave patterns of follicular growth were possible. Conversely, Ginther et al. [15] and 
Knopf et al. [16] favored the two-wave hypothesis, suggesting that differences in wave 
patterns observed among various studies was due to the different cattle populations in 
varying geographical regions. Although their assertion did not deny the presence of three 
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wave patterns, it pointed to more complicated impacts of genetic and environmental 
influences on folliculogenesis among different herds. At the time of these studies, there 
was still considerable debate about the wave hypothesis altogether, as some researchers 
suggested that follicular growth occurs in continuous phases [13]. Eventually, a timeline 
and characterization of the temporal differences between two and three follicular waves 
of development during the estrous cycle emerged [14], which provided great insight 
about the diameters of follicles and the size of the corpus luteum throughout the estrous 
cycle [14]. Overall, the studies of the 1980s established new terminology, such as 
“subordinate” and “dominant” to describe the temporal relationships (size, growth rate) 
among the follicles within the cohort or wave as a proxy to predict their ultimate 
physiological fate.  
The concept of follicular waves in cattle and other mammalian species 
predominates to this day, with the general acceptance that the number of waves can vary 
among individuals [17]. In light of this, investigative focus shifted toward examining 
hormonal regulation and defining the phases of follicular development: recruitment, 
selection/deviation, and dominance. Additionally, researchers sought physiologic 
mechanisms that dictate subordinate and dominant follicular phenotypes [18], [19]. For 
instance, the emergence of a newly recruited follicular cohort, as visualized using 
ultrasonography, occurs 1-2 days following the peak of an FSH surge [20], [21]. 
Cauterization of the first dominant follicle of the first wave 3 days post ovulation relieves 
the suppression of FSH concentrations, which delays regression of subordinate follicles 
and hastens recruitment of the next follicular cohort [20]. These concepts highlight the 
fact that the dominant follicle (of any wave) is responsible for inhibiting subsequent rises 
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of FSH [14], and this effect is due to its increased secretion of estradiol and inhibin [22], 
which ultimately inhibit pituitary FSH through negative feedback mechanisms [23], [24].  
The ability of the dominant follicle to diverge and become self-sustaining in its 
growth has been coined “follicle deviation”.  Follicle deviation has since been adopted to 
encompass the dynamics involved in selection of follicles during folliculogenesis. 
Interestingly, if the dominant follicle is experimentally ablated, the second largest follicle 
of the wave continues its growth and becomes the new dominant follicle of the cohort 
[25]. Moreover, any follicle of the cohort that is 5 mm or larger has the potential to 
become the dominant follicle [26]. Mechanistically, follicular deviation occurs in tandem 
with the establishment of basal concentrations of FSH following the FSH surge [27]. 
Particularly, lower concentration of FSH encourage and maintain granulosa cell 
proliferation and production of estradiol by the dominant follicle, whereas higher 
concentrations impair cell division and stimulate progesterone production [28]. Thus, 
growth of the dominant follicle requires diminishing concentrations of FSH as it 
approaches maturity [29]. The importance of relative size of the follicle in establishing its 
dominance is further underscored by the observation that both LH and FSH receptor 
expression remains relatively unchanged during selection of the dominant follicle [30], 
despite the waning concentrations of available gonadotropins. Follicular dominance is 
generally established at ≥8.5 mm, within an 8 hour window, and only once the follicle 
secretes sufficient amounts of inhibin to impair further FSH secretion [25], [31]. As the 
dominant follicle matures to become pre-ovulatory, it switches from FSH- to LH- 
responsive [32].   
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In recent years, research focus in folliculogenesis has shifted from the temporal 
and hormonal regulation at the systemic level to mechanisms that regulate intraovarian 
dynamics, specifically intracellular signal transduction pathways that influence cell fate. 
Many types of signaling molecules exist in the follicular fluid and are secreted by cells of 
the ovarian follicle: these include insulin-like growth factor-1 (IGF-1), members of the 
transforming growth factor (TGF) - superfamily, fibroblast growth factor (FGF), and 
members of the epidermal growth factor (EGF) family ligands [33]. These pathways have 
multiple functions within the ovary that invoke cellular activities and influence cell fate 
in response to hormonal stimulation. The establishment cell culture methodology to 
sustain bovine ovarian cells in vitro [34]–[36] has helped to characterize key intraovarian 
factors involved. For instance, through the use of a theca cell culture system, 
investigators have found that TGF (an EGF family ligand) increases cellular 
proliferation; while TGF stimulates progesterone production in the presence of estradiol 
[37]. This suggests an inverse relationship, regulated by TGF signaling, possibly exists to 
influence growth and differentiation of follicles. Oocyte-secreted factors of the TGF 
superfamily, such as bone morphogenetic proteins (BMPs) and growth differentiation 
factors (GDFs), protect granulosa cells from apoptosis in cultures of cumulus-oocyte-
complexes [38]. Hence, not only do somatic cells contribute to follicular mechanisms, but 
the oocyte itself likely has an important regulatory role in determining follicular 
dynamics and follicular fate. Initial insight about mechanisms possibly triggering 
follicular atresia has also been obtained using granulosa and theca cell culture systems. 
For instance, Porter et al. demonstrated that Fas antigen mRNA is expressed in granulosa 
cells of follicles, and that granulosa cells of dominant follicles exposed to the LH surge in 
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vivo are resistant to FasL-induced apoptosis [39]. From these observations, Porter et al. 
concluded that GCs from subordinate (atretic) follicles are more susceptible to FasL-
induced killing than those of healthy dominant follicles, suggesting a fundamental 
difference between GCs of the follicular phenotypes, and LH-induced differentiation. 
Collectively, contributions such as these have informed current understanding about the 
regulation of bovine folliculogenesis and the potential cellular mechanisms by which 
hormones and growth factors mechanistically exert their effects.    
 Among the more intensely-studied growth factors associated with the bovine 
ovary are FGF, EGF and TGF. Bovine granulosa cells express a gene encoding for FGF, 
which is hypothesized to develop the vascular system of the theca layer of the follicle 
through paracrine actions [40].  In culture, FGF and EGF help maintain the bovine GC 
phenotype; whereas absence of these factors causes cells to quickly differentiate and lose 
GC characteristics [41], [42]. The effects and interactions of these local growth factors 
can be complex, often altering the actions of other growth factors on cultured follicular 
cells. For instance, TGF produced by thecal cells inhibits the proliferative effect of EGF 
on cultured bovine granulosa cells in a paracrine manner [43]. As the field of growth 
factor research expands, growth factors are now classified into family groups based on 
similar receptor-ligand interactions. For example, TGF is a member of the EGF family 
of ligands. It is expressed in bovine theca cells [44], [45], yet stimulates the proliferation 
of both theca and GCs in vitro [45]. The works of Gospodarowicz et al., Skinner et al., 
and others has affirmed the complexity of growth factor interactions and ligand-induced 
intracellular mechanisms as they pertain to follicular development [46], [47]. As an 
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example, FGF and EGF in combination induce a robust, proliferative response in bovine 
granulosa cells; but they have no proliferative effect independently [48].  
With a clear, demonstrated presence within the ovarian follicle, growth factors are 
plausible local regulators of gonadotropin effects on ovarian cell populations. Among the 
various families of growth factors characterized, for instance, TGF and TGF share an 
inverse yet complementary relationship that impacts proliferation and steroidogenesis of 
bovine thecal cells. TGF increases bovine theca cell proliferation while decreasing 
androstenedione production; whereas TGF inhibits proliferation and stimulates 
progesterone production [37].  In terms of bovine granulosa cells, IGF-1 increases 
estradiol secretion, principally by increasing expression of cytochrome P450 enzymes 
that promote aromatase and steroidogenic activity [49].  As insight is gained about the 
actions of these various growth factors, focus has shifted towards determining the 
signaling pathways that mediate these regulatory actions and determining how these 
factors influence follicular fate.  Very little is known at this point, however, about how 
these mechanisms translate to modulation of bovine follicular dynamics.  
During the past 60 years or more in which research of bovine follicular dynamics 
has been studied, great advances in technology (e.g., ultrasonography, immunoassays, 
and molecular techniques) have led to greater understanding of the growth, maturation, 
and death of follicles, ranging from the systemic to the cellular levels. Folliculogenesis is 
a process requiring many temporally-orchestrated ovarian events; the majority of which 
are regulated both systemically and molecularly. Historical hypotheses and experiments 
put forward have clearly defined the follicular phases, providing opportunities for future 
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scientific pursuits, as well as the potential to manipulate and improve fertility. Continued 
exploration of these phenomena at the cellular and molecular levels will provide new 
insight, and perhaps bring new avenues to benefit agricultural production systems and our 
understanding of the ovarian system in other monovulatory species.  
1.2  Hormonal Regulation of Follicular Dynamics 
The bovine estrous cycle is approximately 21 days in length and is regulated 
through the endocrine actions of hypothalamic, anterior pituitary, ovarian, and uterine 
secreted hormones [17], [50].  The major endocrine hormones involved in this regulation 
are GnRH, FSH, LH, progesterone, and prostaglandin (PGF2). These hormones are 
upregulated and down regulated over the course of the estrous cycle in cattle in response 
to positive and negative feedback systems. GnRH is produced by the hypothalamus and 
stimulates the anterior pituitary to secrete gonadotropins, FSH and LH [51]. Studies first 
linking the pituitary gland to the reproductive organs in animals were reported in 1910, 
when partial removal of the pituitary gland compromised the gonadal function of dogs.  
The gonadal organs of dogs shrank and deteriorated, and the sexual development of 
puppies was interrupted [52]. In 1929, Zondek postulated that the secretions of the 
pituitary gland stimulate the gonads. He observed the timing of their secretion was 
temporally associated with follicular growth and ovulation [53], [54]. These secretions, 
originally known as ‘Prolan A’(later FSH) and ‘Prolan B’(later LH), coordinated the 
rhythm of ovarian events and regulated endometrial function [53]. FSH and prolactin 
were also detected in isolates of the anterior pituitary gland of cattle in 1935 [55]. 
Whereas these hormones ultimately became a large focus of human medical research and 
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infertility treatment in those days, manipulation of their expression to control estrus in 
production animals was also viewed as potentially advantageous. Thus, the combined 
effort of many researchers over the past 100 years has led to considerable understanding 
of the bovine estrous cycle, specifically the behavioral, ovarian, and associated 
physiologic hormonal changes of the cycle. 
Initially, hormonal concentrations of reproductive molecules were difficult to 
study in cattle, but the development and refinement of techniques such as liquid-gas 
chromatography and competitive protein binding techniques changed all this.  
Researchers extracted hormones from circulating blood plasma, and determined their 
relative abundances over the course of the estrous cycle [50], [56]–[58]. Since these 
initial observations, the hormonal regulation of bovine folliculogenesis has been well 
characterized. As previously stated, folliculogenesis consists of three defined phases of 
development that are regulated by these hormonal fluctuations: recruitment, 
selection/deviation, and dominance.  
Recruitment of ovarian follicles is defined by the emergence of a follicular cohort 
from a primordial state. A transient increase in anterior pituitary-derived FSH activates a 
new follicular wave by binding to its receptors on GCs of primordial follicles [20], [59], 
[60].  Experimentally, injections of GnRH can synchronize FSH surges, which  
subsequently stimulate follicular recruitment in cattle [21]. Anti-Müllerian hormone 
(AMH) is secreted by GCs of primordial follicles [61] and is a marker that predicts 
gonadotropin-responsive primordial follicles [62], [63]. Thus, AMH potentially regulates 
follicular recruitment and FSH activation, ensuring that the entire ovarian reserve is not 
depleted in one follicular wave. FSH binding to granulosa cells stimulates proliferation 
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and aromatase activity, enabling the cells to synthesize estradiol [64]–[66] and inhibin 
[67], [68]. LH binds to receptors on theca cells and stimulates the conversion of 
cholesterol to androgen precursors for the granulosa cells to then convert to estradiol.  
These relationships establish an important coordination between the theca and granulosa 
cells in follicular development [69]–[72]. Estradiol secreted by the developing follicles 
asserts a positive feedback mechanism on the hypothalamus to enhance GnRH secretion. 
This effect triggers transient rises in FSH and LH, but FSH secretion is later suppressed 
by the negative feedback effects of follicular inhibin [28]. As the follicles reach 6 mm in 
diameter, a selection event occurs in which one follicle from the cohort continues to grow 
and increase in size while the remaining follicles regress and undergo atresia [73]. 
Ultimately, the largest follicle deviates from its subordinates and continues to grow (i.e., 
becomes dominant), becoming less reliant on FSH stimulation as it produces higher 
amounts of estradiol and inhibin [29].  
Once the dominant follicle reaches ovulatory stage, its granulosa cells become LH 
responsive [74], [75] and estradiol secretion peaks. The estradiol positive feedback on the 
hypothalamic-pituitary axis generates a transient surge in LH secretion, which causes the 
dominant follicle to ovulate [76]–[78]. Following ovulation, both the theca and GCs of 
the ovulatory follicle luteinize to form the corpus luteum and begin to secrete 
progesterone [79], [80]. Although the corpus luteum is the dominant structure on the 
ovary during this time, follicular waves still emerge throughout the estrous cycle. 
However, the high concentrations of circulating progesterone prevents the LH surge 
necessary for ovulation [74], [81]. Dominant follicles of waves that emerge during this 
period of high progesterone secretion are unable to continue their growth and eventually 
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undergo atresia like their subordinates within the cohort. If fertilization and pregnancy is 
not established following ovulation, PGF2 secreted by the uterine endometrium exerts a 
luteolytic effect on the corpus luteum, causing tissue regression and the loss of 
progesterone production [82], [83].  
 
1.3 Reproductive Challenges Associated with Dairy Cattle 
Unique challenges exist in the reproductive management of dairy cattle. In order 
for dairy cows to remain productive and economically valuable, they must produce calves 
every year in order to meet the demands of profitable milk production. High producing 
dairy cattle often experience postpartum anestrus for a number of reasons [84], but the 
most notable reason is the partitioning of energy toward lactation rather than reproductive 
function [85]. Ideally, dairy cattle should become pregnant in early- to mid-lactation. 
However, at this point in time the cows are in negative energy balance metabolically and 
have insufficient energy reserves to support fertilization, let alone a fetus [86]. Energy is 
partitioned away from ovary function, thus negatively affecting follicular growth, 
ovulation, and overall estrous cyclicity [87]. The difficulty of attaining good fertility in 
dairy cattle is also complicated by the trend toward increased herd sizes. Many herds in 
the U.S. average 500 head or more in the milking group, complicating reproductive 
management strategies related to timed artificial insemination (AI) protocols that require 
specific and individual attention to detail [88]–[90]. A better understanding of the 
mechanisms influencing ovarian cyclicity, particularly at the cellular and molecular level, 
may offer insight to improve management strategies and timed AI protocols.   
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1.4 The Bovine Ovarian Follicle 
The intraovarian environment of the follicle is composed of somatic cells (e.g., 
theca and GCs) and the oocyte that secrete a large variety of signaling molecules to 
coordinate processes during development and maturation. These somatic cells and the 
oocyte all have distinctive functions and secrete various autocrine and paracrine 
molecules that harmoniously impact the development and maturation of the follicle and 
its continued growth or atresia/regression. The two main somatic cell types of the ovarian 
follicle are GCs and theca cells. Theca cells are LH responsive and synthesize androgens 
for GC conversion to estrogens [69]–[71], [91]. Theca cells are also important in 
supporting angiogenesis of the follicle [92], [93] and antrum formation [94]. GCs are by 
far the most abundant cell type in the follicle and their proliferation in response to FSH is 
necessary for the initial growth of antral follicles (3-5 mm) [11], [95]. As mentioned 
above, GCs also have an important role in the conversion of androgens to estradiol in 
growing antral follicles [64], [70]. This compartmentalized aspect of steroidogenesis 
within the follicle is known as the “two cell, two gonadotropin hypothesis”, where LH 
receptors and FSH receptors expressed on theca and GCs, respectively, and respond to 
the gonadotropins independently to collectively synthesize estradiol [96], [97]. The initial 
growth of primordial follicles is largely characterized by proliferation and formation of 
gap junctions between GCs, and the growth of the oocyte [98], [99]. Eventually, the zona 
pellucida surrounding the oocyte is formed, and the gap junctions extending from 
granulosa cells to the oocyte are formed. The gap junctions help to maintain the oocyte in 
meiotic arrest [98]. As the GCs proliferate and the follicle grows, estradiol secretion also 
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increases, exerting a positive feedback effect on the hypothalamus to stimulate GnRH 
release, an LH surge, and ultimately ovulation of the dominant follicle [31], [87]. Upon 
ovulation, the somatic cells of the follicle differentiate into luteal cells to form the corpus 
luteum and synthesize progesterone [80], [100]. 
 
1.5 Cellular Mechanisms of Ovarian Follicular Selection 
 Although the primary regulation of ovarian events is carried out by circulating 
gonadotropins and hormones, when it comes to follicular development and maturation in 
response to these hormones, local regulation within the microenvironment of individual 
follicles is imperative. Intrafollicular dynamics influence follicular growth by stimulating 
proliferation of GCs and thecal cells and by protecting the developing oocyte. 
Conversely, these same signaling factors can regulate follicular fate by triggering 
follicular atresia. Although multiple local signaling factors likely coordinate these 
follicular processes and influence follicular fate, IGF-1, through stimulation of 
phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway, is widely-
believed to have the greatest impact on follicular fate and survival during follicular 
selection and deviation. IGF-1 was first suggested to have a regulatory role in the ovarian 
follicle based on its observed ability to stimulate cellular proliferation and differentiation 
in a wide variety of cell and tissue types [101]. Indeed, IGF-1 influences secretion of both 
progesterone [102] and estradiol [49], [103] by GCs. However,  in the presence of LH, 
production of estradiol is attenuated [49], which suggests the stimulatory effect of IGF-1 
on estradiol production by GCs is only relevant to small follicles [102] (i.e. before the 
follicles reach ovulatory stage). IGF-1 stimulates both mitogen activated protein 
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kinase/extracellular regulated kinase (MAPK/ERK) and PI3K/Akt signaling in GCs 
[104], [105]. However, only its effect on PI3K/Akt activation stimulates GC cell cycle 
progression to protect against FasL-induced apoptosis [105]. This observation has been 
put forth as a potential survival mechanim for GCs to protect against follicular atresia.  
IGF-1 also stimulates GC proliferation [103], [106], which supports an active mitotic 
environment for developing follicles. Interestingly, conditional knockdown of the IGF-1 
receptor in GCs results in sterility, with an inability to develop antral follicles and a 90% 
decrease in estradiol production [107]. Thus, it is clear that IGF-1 plays a vital role in 
follicular growth.  
Despite the previous assertion that IGF-1 stimulates both MAPK/ERK and 
PI3K/Akt signaling, the effect on MAPK is not consistent [49].  Moreover, when present 
in high concentrations, IGF-1 makes GCs more prone to apoptosis [49], contradicting the 
idea that IGF-1 alone supports follicular survival. Phosphorylated forms of both ERK and 
Akt (the downstream targets of MAPK and PI3K signaling, respectively) are upregulated 
in follicles destined to become dominant [108]. Both ERK and Akt activation in GC and 
theca cells by IGF-1 and gonadotropins stimulate cell growth and steroidogenic function 
[109]. Thus, although there is some uncertainty about the relative importance of 
MAPK/ERK activation in promoting GC function and follicular survival, it remains 
important to identify specific ligands that stimulate this pathway and evaluate their 
effects. Importantly, down regulation of ERK signaling is associated with apoptosis of 
GCs [110]. The EGF receptor ligands are prominent stimulators of MAPK signaling 
activity [111], therefore their effects are worthy of consideration when investigating the 
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fates of follicles. For instance, EGF and TGF are hypothesized to prevent apoptotic cell 
death of GCs in ovulatory follicles [112]. 
1.5.1 Epidermal Growth Factor Family of Ligands 
During the 1970s, growth factor discovery and classification was prominent; 
growth factors regulating cellular activity was a novel concept and researchers strove to 
improve cell culture systems through their use [113]–[115]. EGF was one of the first 
factors isolated and purified, and is a mitogenic factor in a number of different cells and 
tissues [116]. Growth factors of the EGF family of ligands are associated with 
tumorigenic activity, stimulating cellular growth and differentiation through receptor 
tyrosine kinase (RTK) signaling [117]. EGF family ligands include, but are not limited to, 
TGF, heparin-binding EGF, amphiregulin, betacellulin, epiregulin, and epigen [118], 
[119]. These factors bind to a common receptor (EGFR), which is an RTK that 
heterodimerizes and is activated through autophosphorylation, and stimulates multiple 
signaling pathways within cells, including MAPK and PI3K [119]–[121]. MAPK 
activation through this receptor requires the recruitment of the Grb2 adaptor protein, and 
the formation of a Grb2/Sos complex to activate Ras; whereas PI3K signaling can be 
activated directly [122]. 
The molecule EGF, specifically, influences ovarian signaling and cellular 
regulatory mechanisms. For example, EGF stimulates GC proliferation in cells derived 
from large follicles, but once the cells luteinize the proliferative response is attenuated 
[123]. EGF also regulates steroidogenic functions, including the enhancement of 
progesterone production [46], which suggests it augments GC differentiation, possibly 
during post-ovulatory processes. In the pig, EGF is present in follicular fluid [124] and 
 17 
promotes GC proliferation in vitro [106]. Furthermore, proliferation is synergized when 
combinations of TGF and IGF-1 are included in the treatments [106]. However, EGF 
was the only growth factor in the study to stimulate proliferation independently. TGF 
and IGF-1 failed to stimulate cell number and DNA synthesis [106], further supporting 
the concept that IGF-1 alone is insufficient to promote GC growth.  
Since its original discovery and characterization in murine cells [125], [126]  
TGF continues to be viewed as closely related to EGF, sharing a common membrane 
receptor. However, TGF and EGF do not exert the same biological actions [127], and 
each has specific and unique functions in cellular activities. May and Shomberg 
speculated that TGF and EGF have separate actions in ovarian function, with TGF 
being more important in luteal formation due to its ability to stimulate angiogenesis and 
wound healing in other tissues [128]. Consistent with the observation that EGF induces 
progesterone production, TGF prevents FSH-stimulated aromatase activity in rat 
granulosa cells [129]. Conversely, this same study demonstrated an augmentation of 
aromatase activity by TGF, and postulated that TGF may be the more influential 
transforming growth factor in the regulation of ovarian cyclicity [129]. TGF is localized 
to the theca-interstitial cells of rat ovaries [130], and this is consistent with a study of the 
bovine ovary [44]. Together, these studies establish TGF is theca-derived. A more 
recent study, however, indicates TGF is also present in the oocytes of bovine follicles 
[131], which suggests multiple cellular sources of TGF exist in the follicle. 
In bovine GCs, TGF inhibits the secretion of estradiol, inhibin A, activin A, and 
follistatin both independently and in the presence of FSH and IGF-1 stimulation [131].  
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Under these same conditions, TGF also stimulates cellular proliferation [131], which 
suggests a modulatory role of  TGF during early follicular development. Others report 
that TGF prevents spontaneous apoptosis of rat granulosa cells in culture [132]. Thus, 
TGF exerts potent proliferative and somewhat protective effects in cultured GCs, which 
suggests a possible regulatory role in the selection and/or survival of the dominant 
follicle.  
1.5.2 Transforming Growth Factor-alpha in the Bovine Ovary 
Characterization of TGF in the bovine follicle since the late 1980s and early 
1990s is limited [47]. TGF is secreted by bovine theca cells [44], [133] into the 
follicular fluid where it can act in a paracrine manner to decrease estradiol production by 
GCs from large follicles (>10 mm) [134]. Although it impairs bovine GC 
steroidogenesis, TGF also stimulates cell proliferation [37], indicating that it may also 
prevent cellular differentiation. TGF stimulates cumulus GC function, which in turn 
supports the maintenance of high quality oocytes [135]. No other literature about TGF 
in the bovine follicle seemingly exists until the early 2000s, when Glister and colleagues 
localized TGF to the bovine oocyte [131], and showed the paracrine action of TGF to 
suppress estradiol and inhibin secretion by GCs in response to FSH and IGF-1 [131], 
[136]. These authors proposed that TGF mediates the actions of oocytes on GCs. 
Additionally, this study initially established the novel and diverse functions of TGF, as 
compared to EGF, by showing that EGF is undetectable in the same oocytes [131].  
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1.5.3 Mechanisms of Follicular Atresia and Apoptosis 
The idea that cell death is an organized and regulated process through apoptotic 
signaling was first presented in the 1970s when Kerr et al. summarized evidence from 
multiple studies to characterize the process, and established it as a “basic biological 
phenomenon” that balances mitosis with cell turnover [137]. The process of programmed 
cell death occurs in two phases: the first entails condensation of the nucleus and 
cytoplasm, and their subsequent fragmentation into “apoptotic bodies”, the second 
consists of phagocytosis of the apoptotic bodies by other surrounding cells. Based upon 
the criteria established by Kerr et al., the ovary soon became an attractive model to study 
these mechanisms due to its dynamic and constant cellular remodeling, particularly in the 
context of ovulation and luteal function. With regard to follicular dynamics, apoptosis is 
an extremely important process because the majority of follicles within the ovary fail to 
become dominant, and instead undergo atresia [138]. This newly defined apoptotic 
phenomenon was characterized in ovine follicles based upon observations of cellular and 
nuclear fragmentation, and the subsequent phagocytosis of these fragments [139] [140].  
Granulosa cells of the follicle are among the most severely affected. 
By the early 1990s, apoptosis became widely accepted as a common process by 
which follicular atresia ensued, and that granulosa cells were the main cell type targeted 
[112], [138], [141]–[143]. A shift from identifying the cell types undergoing apoptosis 
within the follicle to determining the mechanisms of atresia occurred. Several locally 
produced cytokines are associated with apoptotic events during follicular atresia. Among 
these, tumor necrosis factor- (TNF-) invokes apoptosis in cultured rat antral follicles 
and decreases aromatase activity in cultured granulosa cells [144]–[146]. TNF--induced 
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effects are mediated through the secondary messenger, ceramide [144]. Fas ligand 
(FasL), a member of the TNF family of ligands, is also thought to contribute to follicular 
atresia. Its receptor, Fas, is a member of the TNF family of cellular membrane receptors 
[147]. Abundant amounts of Fas expression are seen in cells of mouse ovaries [148], 
[149], in bovine theca and GCs [39], [150], and in hen GCs [151], particularly during 
episodes of follicular atresia.  In cultured bovine GCs, FasL-induced apoptosis is 
enhanced by serum withdrawal [152], and is modulated by the presence of growth factors 
[153]. For these reasons, Fas is commonly considered the mediator of GC apoptosis and 
follicular atresia [154].  
 
1.6 Hypotheses, Aims, and Objectives 
 
In the current study, our working hypothesis was that growth factors, through 
increases in MAPK/ERK signaling, provide resistance to FasL-induced apoptosis in 
bovine GCs during folliculogenesis. Particularly, GCs fundamentally support the early 
growth of small ovarian follicles through their proliferation and cellular signaling. This 
proliferation is largely supported by the actions of intrafollicular endocrine molecules 
which act to stimulate and support GC proliferation, and, ultimately, follicular survival. 
The specific objective was to determine if an enhancement of ERK signaling in bovine 
GCs provides resistance to Fas-mediated apoptosis as a possible cellular mechanism for 
follicle persistence and selection.  
 
The specific aims were to: 
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(1) Evaluate the effects of growth factor stimulation on MAPK/ERK signaling 
in bovine GCs, 
(2) Reproduce the apoptotic effects of FasL on cultured bovine GCs, and 
(3) Demonstrate that MAPK/ERK signaling mediates the protective effect of 
growth factors on FasL-induced apoptosis  
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CHAPTER 2: PRELIMINARY EXPERIMENTS 
 
2.1 Introduction 
To investigate the stated objective and aims, it was imperative to first survey and 
profile which growth factors stimulate bovine GCs in our unique, serum-free culture 
system established in the Townson laboratory. Many of the previous growth factor 
studies reported in the literature utilized culture systems in which GCs are isolated from 
follicles, pooled together from several animals, and then treated with growth factors in 
which the culture medium contains varying amounts of fetal bovine serum (FBS). In cell 
culture systems, FBS is utilized to support successful cellular growth, differentiation and 
maintenance in in vitro environments and has been used to promote cellular adhesion of 
GCs to culture flasks following isolation [155], [156]. Without question, FBS inherently 
contains of variety biomolecules and cell growth promoting constituents at undefined 
concentrations, which could confound effects of added growth factors. Conversely, in our 
culture model, the cells are maintained in a serum-free system in which the constituents 
of the culture medium are defined, and the effects of growth factors can be individually 
or collectively evaluated. Additionally, the cultures of GCs are established using ovary 
pairs collected from an individual cow (i.e., the cow is the experimental unit) to avoid 
any confounding effects attributable to pooling of cells from several animals. For these 
reasons, the preliminary experiments described herein were intended to evaluate the 
effects of several growth factors individually and collectively to ensure that any 
stimulatory effects were consistent with those previously reported in the literature. 
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Additionally, the purpose of this screening was to identify particular growth factors that 
induced a proliferative response mediated by MAPK/ERK stimulation.  
2.2 Materials and Methods 
2.2.1 Review of Literature 
A review of the literature, summarized above, was completed to gain 
understanding and an introductory perspective about the various growth factors that exist 
and that potentially impact the ovarian follicular microenvironment. The growth factors 
that were identified as plausible candidates for the thesis work, and that were further 
discussed among the thesis committee members for further profiling were FGF, EGF, 
TGF , TGF, and IGF-1. These growth factors were then tested in dose-response and 
time-course experiments to evaluate their efficacy in stimulating bovine GC proliferation, 
and as a lead-in to examining growth factor-induced MAPK/ERK signaling.  
2.2.2 Cell Culture and Reagents 
Pairs of bovine ovaries were obtained from Champlain Beef (Whitehall, NY) and 
transported to the laboratory in 0.9% NaCl solution supplemented with antibiotic-
antimycotic at room temperature. All ovaries were collected and processed within 4-5 
hours of slaughter. All small (3-5mm) antral follicles were aspirated to obtain bovine 
GCs. Small (3-5mm) follicles were selected due to follicular dominance not being 
achieved until a follicle has reached a diameter of 8-10mm, indicating that granulosa and 
follicular fate would not be decided at a small follicular size. The GCs obtained from 
each ovary pair were kept separate, rather than pooled, for the culture experiments. 
Hence, a given culture consisted of cells obtained from a single pair of ovaries, making 
an individual cow the experimental unit (n = 3). The retrieved cells were pelleted, 
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resuspended, and seeded into individual T25 flasks. Cells were cultured in Dulbecco’s 
Modified Eagle Medium/Ham’s F12 Nutrient Mixture (DMEM/F12) medium initially 
containing 10% FBS and antibiotic-antimycotic (complete culture medium) and 
incubated in a humidified incubator at 37C with 5% CO2  until the cultures reached 
confluency (~3-4 days). Once confluent, the cells were passaged, enumerated, and 
subsequently seeded into culture vessels for further testing. The day after seeding, the 
cultures were switched to serum-free DMEM/F12 medium supplemented with insulin-
transferrin-selenium (ITS) (10 ng/ml insulin, 5.5 ng/ml transferrin, 0.67 pg/ml sodium 
selenite), without or with specific concentrations of growth factors. The growth factors 
tested were recombinant human epidermal growth factor (EGF; Gibco), recombinant 
human transforming growth factor-1 (TGF; R&D Systems), recombinant human 
transforming growth factor- (TGF; R&D Systems), and human insulin-like growth 
factor-I (IGF-1; Cell Signaling Technology). The growth factors selected were 
determined based on materials used throughout previous studies reported in the literature. 
 
2.2.3 Growth Factor Effects on Cellular Proliferation 
Bovine GCs were seeded into clear-walled, 96-well plates (5,000 cells/well for 
individual growth factor tests and 10,000 cells/well for combined growth factor tests) 
using complete culture medium. The following day, the cells were switched to serum-free 
medium containing individual or combined concentrations of the growth factors (0, 1, 10, 
and 100 ng/mL) and incubated for 24 or 48 hours. Complete culture medium (containing 
FBS) was used as the positive control for proliferation, and staurosporine (a 
chemotherapeutic agent that induces apoptosis) was used as the negative control and 
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successfully abolished any proliferative effect of all treatments and killed the cells, 
detected both observationally and by no detectable level of MTS absorbance (data not 
shown). Following the time of treatment, relative proliferation of bovine GCs was 
assessed using an MTS assay (CellTiter 96 AQueous One Solution Cell Proliferation 
Assay, Promega) in which the absorbance at 490 nm was measured and recorded using a 
BioTek Synergy HT plate reader (BioTek).  
2.2.4 Growth Factor Effects on Cellular Proliferation 
All experiments were conducted using a minimum of three biological replicates 
from an independent pair of ovaries (i.e., cow is the experimental unit). Data were 
analyzed by one-way analysis of variance (ANOVA), followed by a Student’s T-Test. 
Differences among means were considered significant at p<0.05. 
2.3 Results 
2.3.1 Effects of Individual Growth Factors on Bovine Granulosa Cell Proliferation 
 
Figure 1.  MTS Assay analysis of bovine granulosa cell proliferation in response to growth factor 
treatment (TGF, TGF, IGF-1, and EGF). Bars represent means of recorded absorbance values at 
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490 nm  SEM (n = 3 ovary pairs) for bovine granulosa cells exposed to different concentrations of 
each growth factor (0, 1, 10, or 100 ng/mL) for 24 hours . The same absorbance value patterns were 
seen after 48 hours of treatment, with the recorded values raised slightly.  
 
 All growth factors examined suggested an induced a proliferative response in 
comparison to control treatment (Figure 1). No statistical difference among treatments or 
doses was identified, but this was most likely attributed to the low number of ovary pairs 
utilized for the experiments. Among the 4 growth factors tested, TGF  was qualitatively 
the most potent, reaching a maximal response at 10 ng/mL (Figure 1). TGF and EGF 
were the least potent qualitatively (Figure 1), with EGF being the only growth factor to 
suggest  a dose-dependent trend.  Effects of IGF-1 treatment were intermediate to TGF 
and the other growth factors (Figure 1). Following 48 hours of treatment, the same 
proliferation trend was observed, and all treatments showed a similar amount of increase 
in absorbance values (data not reported).  
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2.3.2 Combined Growth Factor Effects on Bovine Granulosa Cell Proliferation 
 
Figure 2.  MTS Assay analysis of bovine granulosa cell proliferation in response to growth factor 
treatment combinations including TGF. Bars represent means of recorded absorbance values at 
490 nm  SEM (n = 3) for bovine granulosa cells exposed to a 10 ng/mL concentration of each growth 
factor combination for 24 hours. 
  
All possible treatment combinations of the growth factors were evaluated at 
multiple doses (0, 1, 10, and 100 ng/mL). However, for ease of interpretation, only the 
growth factor combinations that included TGF at the 10 ng/mL dose are depicted here. 
Overall, and unexpectedly, the proliferative responses here were not as robust as in 
previous experiments (Compare Figures 1 and 2). This was attributed to higher seeding 
densities (10,000 cells/well) established in these experiments, which presumably 
predisposed the cells to premature contact inhibition. Nevertheless, TGF, when 
combined with either TGF or IGF-1, somewhat augmented the  proliferative response, 




Based upon the observed effects of growth factor stimulation on bovine GC 
proliferation, TGF was selected as the candidate stimulator of proliferation among the 
four growth factors tested. Seeding methods between the two experiments (individual and 
combined growth factor experiments) differed and were inconsistent because the 
investigator had not yet developed consistent seeding techniques. Nevertheless, based 
upon the results of the individual growth factor experiments, and the apparent lack of 
published studies describing TGF effects in bovine GCs, TGF was selected as the 
growth factor of consequence for further study. In addition, there was evidence in the 
literature at the time that TGF induces an upregulation of phosphorylated ERK1/2 
expression in the granulosa-like, KGN cells [157]. We therefore hypothesized that TGF 
has similar actions in bovine GCs, which warranted further testing. 
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CHAPTER 3: EFFECTS OF TGF ON PROLIFERATION, MAPK/ERK SIGNALING 
AND CYTOKINE-INDUCED APOPTOSIS IN BOVINE GRANULOSA CELLS 
3.1 Introduction 
Ovarian folliculogenesis is a dynamic process in which cohorts of follicles are 
recruited and develop during selected periods of the estrous cycle [13], [14], [17], [158], 
[159]. The process involves highly-coordinated and regulated interactions between the 
systemic, pituitary-derived gonadotropins and their cellular targets at the ovarian level 
(i.e., granulosa and theca cells and the oocytes). Cohorts of antral follicles emerge within 
the ovary following an episodic surge in follicle stimulating hormone (FSH) [20]. These 
follicles continue to grow and develop in synchrony due to proliferation of granulosa and 
thecal cells and the development of the antrum [94], [160]. However, as the follicles 
mature, a selection or deviation event occurs in which one follicle continues its growth to 
become dominant, whereas the remaining follicles of the cohort become subordinate and 
are vulnerable to atresia [73]. The dominant follicle then either ovulates or undergoes 
atresia similar to its subordinates. Its fate depends upon on the phase of the estrous cycle 
and the relative concentration of circulating progesterone [161]–[163]. The coordination 
of the fates of these follicles is influenced by a vast array of autocrine and paracrine 
regulators, including growth factors. In particular, growth factors are viewed as being 
critical for selection of the dominant follicle and its deviation in growth from the 
remaining follicles [33], [163]. 
 There are a variety of growth factors within the ovary that not only stimulate the 
growth of follicles, but also influence follicular fate (i.e., continued growth or atresia). 
These include, insulin-like growth factor-1 (IGF-1; [101], [164]), epidermal growth 
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factor (EGF; [44], [165], [166]), fibroblast growth factor (FBF; [132], [167]) and the 
superfamily of transforming growth factor-beta (TGF; [168]). The cellular actions of 
these growth factors are invoked principally through stimulation of multiple intracellular 
signaling pathways, including receptor tyrosine kinase (RTK; [120], [169]), protein 
kinase B (PI3K/Akt; [49], [170]), mitogen-activated protein kinase (MAPK/ERK; [26], 
[27], [30]) and the Smad pathways ([173]). In recent years, oocyte-derived TGF 
molecules, such as growth differentiation factors (GDF; [174], [175]) and bone 
morphogenic proteins (BMP; [176], [177]) have attracted increased attention because of 
their influence on granulosa cell (GC) and cumulus cell function, including proliferation, 
steroidogenesis, differentiation, and apoptosis [177]–[179]. The concept that the oocyte 
influences its own fate is particularly intriguing. However, TGF superfamily members 
are not the only oocyte-derived factors that can influence follicular fate.  
 The EGF family of growth factors can also impact follicular fate by affecting GC 
function [111]. Most notably, EGF family growth factors stimulate differentiation of GCs 
and regulate steroidogenic function through the attenuation of GC production of estradiol 
and inhibin, particularly in response to luteinizing hormone (LH) [111]. One such family 
member, TGF, is a potent mitogen that stimulates cell growth through rapid activation 
of MAPK/ERK and PI3K/Akt signaling [157]. Strong mitogens also likely promote GC 
survival in the midst of follicular selection and deviation. EGF family members have 
similar structure to one another, and bind to a common receptor (EGFR) to stimulate a 
variety of ligand-specific cellular functions; including activation of RTK signaling, which 
can simultaneously trigger both PI3K/Akt and MAPK/ERK pathways, and influence 
cellular proliferation and differentiation [180]. EGFR ligands have diverse functions in 
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multiple tissue types, and are particularly important factors involved in ovarian follicle 
maturation and ovulation [118].  
Stimulation of MAPK/ERK and PI3K/Akt signaling in GCs is particularly 
important in oocyte-GC communications within the follicle. MAPK/ERK signaling is 
activated by both follicle stimulating hormone (FSH) and LH stimulation in porcine GCs, 
with LH stimulating the more rapid response [181]. In rat GCs, FSH activates 
MAPK/ERK signaling and contributes to follicular growth and differentiation [182]. 
PI3K/Akt signaling promotes follicular survival through stimulation of cell proliferation, 
transcription of FOXO3a (protecting cells from oxidative stress), and phosphorylation of 
BAX (which prevents apoptosis) [170]. Phosphorylation of ERK and Akt in these 
signaling pathways is higher in dominant follicles than subordinate follicles [171], and 
their expression is upregulated in GCs of future dominant follicles before follicle 
selection has occurred [108]. 
 In the bovine ovary, TGF, which is known to stimulate both MAPK/ERK and 
PI3K/Akt signaling [157], is expressed in both the oocyte and surrounding thecal cells 
[44], [131]. It is thought to promote follicular growth through paracrine stimulation of 
GC proliferation [45]. Thus, TGF and its actions through intracellular signaling may be 
an important mechanism influencing follicular fate and the establishment of follicular 
dominance. Effects of TGF on GC steroidogenesis is both stimulatory [183] and 
inhibitory [134], but there is a general lack of knowledge about the direct effects of 
TGF on bovine GC intracellular signaling and downstream effects like cytokine-
induced apoptosis. In the current study, the objective was to evaluate these effects of 
TGF on GCs obtained from bovine small (3-5mm) antral follicles. Cells were obtained 
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from small follicles to ensure that a selection event had not yet occurred. TGF was 
hypothesized to stimulate bovine GC proliferation and survival via a MAPK/ERK-
mediated mechanism. 
 
3.2 Materials and Methods 
3.2.1 Cell Culture and Reagents 
Pairs of bovine ovaries were obtained from Champlain Beef (Whitehall, NY) and 
transported to the laboratory in 0.9% NaCl solution supplemented with antibiotic-
antimycotic at room temperature. All ovaries were collected and processed within 4-5 
hours of slaughter. All small (3-5 mm) antral follicles were aspirated to obtain bovine 
GCs. The GCs obtained from each ovary pair were kept separate, rather than pooled, for 
the culture experiments. Hence, a given culture consisted of cells obtained from a single 
pair of ovaries. The retrieved cells were pelleted, resuspended, and seeded into 
independent T25 flasks. Cells were cultured in Dulbecco’s Modified Eagle 
Medium/Ham’s F12 Nutrient Mixture (DMEM/F12) medium containing 10% FBS and 
antibiotic-antimycotic (complete culture medium) and incubated in a humidified 
incubator at 37C with 5% CO2 until the cultures reached confluency (~3-4 days). Once 
confluent, the cells were passaged, enumerated, and subsequently seeded into culture 
vessels for further testing. The day after seeding, the cultures were switched to serum-
free DMEM/F12 medium supplemented with insulin-transferrin-selenium (ITS) (10ng/ml 
insulin, 5.5ng/ml transferrin, 0.67pg/ml sodium selenite), without or with specific 
concentrations of growth factor, cytokines, and/or inhibitors (see details below) 
depending upon the experiment.   
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3.2.2 Cell Treatment and Cell Proliferation 
Bovine GCs were seeded into clear-walled, 96-well plates (5,000 cells/well) using 
complete culture medium. The following day, the cells were switched to serum-free 
medium containing recombinant human TGF (R&D Systems; 1, 10, or 100ng/mL) and 
incubated for 24 hours. Following 24 hours of treatment, relative proliferation of bovine 
GCs was assessed using an MTS assay (CellTiter 96 AQueous One Solution Cell 
Proliferation Assay, Promega) in which the absorbance at 490 nm was measured and 
recorded using a BioTek Synergy HT plate reader (BioTek). 
3.2.3 Cell Treatment and Western Blot Analysis 
Aliquots of bovine GCs were seeded in 6-well plates (150,000 cells/well) using 
complete culture medium. The following day, the cells were serum-starved for 4 hours, 
and then treated with recombinant human TGF (TGF)(R&D Systems; 10ng/mL) for 2 
hours. MAPK inhibitor, U0126 (Millipore; 10M), was applied 1 hour prior to TGF 
treatment. Following treatments, the cells were washed twice with ice-cold PBS solution 
and lysed using RIPA buffer and scraping. The cell lysates were then transferred to 
1.5mL tubes and passed through a 27-gauge needle. Protein concentration of each sample 
was determined using the PierceTM BCA Protein Assay Kit (ThermoFisher). 10g of total 
protein was loaded into the wells of a Mini-PROTEAN TGX Stain-Free Precast Gel 
(BioRad) and separated using electrophoresis. Separated proteins were then transferred to 
a PVDF membrane (BioRad) using a semi-dry transfer unit (Hoefer TE70XP), and the 
resulting blot was blocked with TBST containing 5% BSA and then probed with primary 
monoclonal antibodies for pERK1/2 (rabbit; cat# 4370) and ERK1/2 (mouse; cat# 4696). 
Goat-anti-rabbit and rabbit-anti-mouse antibodies, respectively, conjugated with HRP 
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were used in conjunction with Clarity Western ECL Substrate (BioRad) for imaging 
using the BioRad ChemiDoc Imager. All antibodies were obtained from Cell Signaling 
Technology. Immunoblots consisted of at least 3 biological replicates that were run either 
in duplicate or triplicate.  
3.2.4 Fas Ligand-induced Apoptosis 
To evaluate the effects of TGF on the incidence of FasL-induced apoptosis, bovine GCs 
were seeded either in 24-well plate (50,000 cells/well) or white-walled 96-well plates 
(5,000 cells/well) in complete culture medium. The following day, the cells were 
switched to serum-free medium containing either DMSO (0.1%), or U0126 (10M) and 
incubated for 1 hour. Following inhibitor pre-treatment, growth factor treatments were 
applied, and cells were incubated for an additional 24 hours. The growth factor tested was 
TGF (100ng/mL). Dosing was based upon preliminary experiments (data not shown) 
and dosing used in previous publications [157]. Following growth factor treatment, 
recombinant human Fas Ligand (FasL) (EMD Millipore; 100ng/mL) was applied and the 
incidence of apoptosis was determined visually (24-well plates – photographic images 
taken at hour intervals for 8 hours) or by using a caspase assay (96-well plates - Caspase-
Glo 3/7 Assay, Promega; detection run after 6 hours of FasL treatment). 6-hour FasL 
treatment was determined through time-course observation of sufficient induction of cell 
death and anticipated caspase activity before the administration of the Caspase Assay. 
RLU values from the caspase assay were recorded using a BioTek Synergy HT plate 
reader. Cells cultured in complete medium (i.e. 10% fetal bovine serum) throughout the 
experimental period were used as the positive control to test for protection against 
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cytokine-induced apoptosis. These experiments were conducted using 3-7 biological 
replicates.  
3.2.5 Statistical Analysis 
All experiments were conducted using a minimum of three biological replicates 
from an independent pair of ovaries (i.e., cow is the experimental unit). Data were 
analyzed by analysis of variance (ANOVA), followed by a Student’s T-Test. Differences 
among means were considered significant at p<0.05.   
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3.3 Results 
3.3.1 TGF stimulates bovine granulosa cell proliferation 
 
Figure 3.  MTS Assay analysis of bovine granulosa cell proliferation. Bars represent means of 
recorded absorbance values at 490 nm  SEM (n = 7 ovary pairs) for bovine granulosa cells exposed 
to different concentrations of TGF (0, 1, 10, or 100 ng/mL) for 24 hours. Different letters denote 
differences in proliferation induced as a result of TGF treatments (p<0.05). 
Dose-response experiments evaluating the effect of TGF on bovine GC 
proliferation during a 24-hour culture indicated that cell numbers increased at the 10 and 
100ng/mL doses (Figure 3). Conversely, TGF had no effect at the 1ng/mL dose. Based 
on these observations, the higher doses of TGF were used in all subsequent 
experiments. 
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Figure 4.  Immunoblot detection of pERK1/2 and ERK1/2 in bovine granulosa cells following 
exposure to TGF (10 ng/mL) and/or MAPK inhibitor, U0126 (10 M). a.) Representative 
immunoblot of pERK1/2 and ERK1/2 in response to treatments. b.) Bars representing mean 
densitometry results of immunoblots  SEM (n = 3 ovary pairs). Relative expression is normalized to 






differences in protein expression among the treatments (p<0.05). Treatment and inhibitor effects 
were evaluated on relative protein expression quantified through the densitometry analysis. Data are 
representative of 3 biological samples run in duplicate or triplicate. 
 
 MAPK signaling was stimulated in bovine GCs following TGF (10 ng/mL) 
treatment, based upon the upregulation of phosphorylated ERK1/2 expression (Figure 
4A). Densitometry analysis confirmed the upregulation to be 7-fold higher than that of 
control samples (p<0.05; Figure 4B). This upregulation was attenuated, however, by the 
MAPK inhibitor, U0126 (10M), which effectively reduced phosphorylated ERK1/2 
expression to a level comparable to control (p<0.05; Figures 4A and B). 
3.3.3 TGF fails to prevent Fas ligand-induced apoptosis of bovine granulosa cells 
 
Figure 5. Representative images of bovine granulosa cells treated with FasL either with or without 
TGFα (100 ng/mL). Cells were imaged on an hourly basis for 8 hours, images up to 6 hours are 
shown. The presence of refractive and detached cells is indicative of cell death in response to FasL   
(n = 3 ovary pairs). 
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Figure 6. Caspase 3/7 activity assay analysis of bovine granulosa cells following 24-hour treatment 
with TGFα (100 ng/mL), followed by a 6-hour exposure to FasL (100 ng/mL). The MAPK inhibitor, 
U0126 (10 µM) or vehicle control, DMSO (0.01%) was applied to the cells 1 hour prior to TGFα 
treatment. Treatment groups denoted with an asterisk (*) are different from the control group 
(p<0.05). Bars having a different letter are statistically different (p<0.05; n = 7 ovary pairs).   
 24-hour pre-treatment of bGCs with TGF (100ng/mL) failed to provide any 
protective effect against FasL-induced cell death (Figure 5). Signs of cell death in the 
presence of FasL (i.e., refractive and detached cells in the culture) were observed as early 
as 3 hours post-treatment (Figure 5.).. By 6 hours, most of the cells were dead or dying 
and had become detached from the culture vessel (Figure 5). Comparatively, cells treated 
with TGF had greater viability over the course of the culture period compared to cells in 
serum-free control medium (Figure 5).  In fact, the cells looked similar to those cultured 
in FBS-containing, complete culture medium (images not shown).  FasL-induced cell 
death via apoptosis was evidenced by the increased expression of caspase 3/7 activity 
(Figure 6). Interestingly, and unexpectedly, exposure of the cells to TGF enhanced 
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susceptibility to FasL-induced apoptosis as compared to FasL alone (Figure 6); this effect 
was observed regardless of MAPK inhibition (U0126), suggesting that TGFα-induced 
MAPK stimulation provided no protection against FasL-induced apoptosis. Conversely, 
FBS included in the culture medium abolished the FasL killing effect and protected 
against the induction of apoptosis. (data not shown).    
 41 
CHAPTER 4: GENERAL DISCUSSION 
In the work presented here bovine GCs were exposed to TGF to test the 
hypothesis that TGF, through increases in MAPK/ERK signaling, provides resistance to 
immune-mediated apoptosis. In so doing, it was determined that TGF stimulates a 
proliferative response in bovine GCs and does this through activation of MAPK/ERK 
signaling, as evidenced by an increase in the phosphorylation of ERK proteins. The use 
of the MAPK inhibitor, U0126, showed the specificity of TGF-induced MAPK/ERK 
signaling by completely abolishing the expression of phosphorylated ERK. In our serum-
free culture system, it was also determined that Fas Ligand induces apoptosis of bovine 
GCs, as evidenced by an increase in caspase 3/7 activity, and the effect is augmented by 
prior exposure of the cells to TGF.  Lastly, although TGF induced bovine GC 
proliferation and stimulated MAPK/ERK signaling, there was no evidence to support the 
hypothesis that MAPK/ERK signaling mediates a protective effect of TGFα on FasL-
induced apoptosis. These observations collectively cast doubt on the likelihood that 
TGFα, and MAPK/ERK signaling in particular, support granulosa cell survival and 
follicular persistence during follicle selection and deviation. 
 A substantial amount literature exists in which effects of various intrafollicular 
signaling molecules have been investigated. However, TGF has seemingly been 
overshadowed by these and its better-known family member, EGF.  Nevertheless, the 
current study contributes to the existing literature and adds to our current understanding 
of the molecular dynamics influencing ovarian physiology.  For instance, results from the 
current study support the concept of direct effects of TGF on bovine GCs, which 
include stimulation of cell proliferation and the upregulation of MAPK/ERK signaling. In 
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work of others, TGF induced a proliferative response in primary cultures of GCs from 
cattle [131] and rats [184], as well as in immortalized GC lines [157], but the mechanistic 
effects were not entirely elucidated. TGF induces proliferation of KGN cells (a 
granulosa cell tumor line) through EGFR stimulation and activation of multiple 
pathways, including mTOR, PI3K/Akt, and MAPK/ERK [157]. TGF is more potent 
than EGF as a mitogen, but the effect are attributed to PI3K/Akt and mTOR, rather than 
MAPK/ERK, activation [157].  Conversely, in current study, the proliferative effect of 
TGF on bovine GCs appeared to be attributable to the stimulation of MAPK/ERK 
signaling. The MAPK inhibitor, U0126, effectively negated TGF-induced effects on 
ERK1/2 phosphorylation. In both the current and previous study [157],  the TGF-
induced phosphorylation of ERK occurred within 10 minutes of treatment and was 
sustained for up to three days of culture. These observations suggest TGF is indeed a 
potent activator of MAPK/ERK signaling, and lends credibility to the idea that 
interactions between MAPK/ERK and PI3K/Akt signaling occur and promote cell 
survival [185], [186].   
 The current results also support the previous findings of Glister and co-workers 
[131], who demonstrated that TGF is expressed in bovine oocytes and stimulates GC 
proliferation when co-cultured with oocytes [131]. GCs do not express TGF mRNA 
[45], so there is no evidence that TGF is a GC-derived molecule. Beyond stimulating 
GC proliferation, TGF also inhibits estradiol, inhibin, activin, and follistatin secretion 
by GCs, but has no effect on progesterone production [131]. From these observations, 
Glister and colleagues suggested a role for TGF in GC-oocyte interactions.  However, 
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as has become evident from the current study that the role of TGFα may be more 
selective to the dominant follicle, particularly during ovulation and subsequent luteal 
function, because TGFα fails to prevent FasL-induced apoptosis and most likely would 
fail to protect against follicular atresia. The effects of TGF on bovine GC and theca 
cells occur through EGFR stimulation [45]. Another growth factor, EGF, is also a potent 
stimulator of GC proliferation [42]. Related molecules of the EGF family are expressed 
and stimulate follicular growth in multiple species including chickens [187], goats [188], 
pigs [124], and humans [189]. However, TGF is considered the major EGF ligand 
within cow follicles [131], and may have a unique, mechanistic role in the follicle that 
has yet to be characterized and understood.    
Theca cells and/or oocytes are the principal sources of EGF and TGF secretion 
in the ovary and possibly have paracrine effects on GCs through the EGFR [45], [165], 
[190], [191]. In bovine GCs, the activation of both MAPK/ERK and PI3K/Akt signal 
transduction promotes cell growth and viability, which is thought to translate to 
development and differentiation of follicles [108]. Differences in the expression of 
MAPK/ERK and PI3K/Akt proteins are evident between large and small follicles, but 
more importantly, the difference in their expression occurs just after the emergence of the 
“putative” dominant follicle [108]. Dominant follicles have higher expression of the 
phosphorylated forms of ERK and Akt than subordinate follicles [171]. Elevated 
expression of pERK and pAkt are detectable in the putative dominant follicle, and are 
detectable before any other distinguishable markers, such as changes in follicular size or 
estradiol production, become evident [108]. Thus, MAPK/ERK and PI3K/Akt signal 
transduction may join forces to provide a selective advantage to follicles as they attain 
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dominant status. In the current study, TGF clearly upregulated pERK expression in 
bovine GCs, and we suggest that this effect occurs through MAPK/ERK activation. 
Indeed, pERK expression is completely abolished by the MAPK inhibitor, U0126, which 
confirms that the effects of TGF in bovine GC is mediated, at least in part, through the 
MAPK/ERK pathway. Despite this, stimulation of MAPK/ERK signaling failed to 
provide any protective effect against cell death in the FasL experiments. The lack of 
protective effect was somewhat surprising because others report that a reduction in ERK 
expression leads to apoptotic signaling [192]. In porcine GCs, for example, ERK 
expression aids in cell survival during times of oxidative stress [172]. Although 
considerable crossover exists between MAPK/ERK and PI3K/Akt signaling [185], [193], 
and the expression of these two pathways differs between putative dominant and 
subordinate bovine follicles [108], the question of which of these signaling mechanisms 
ultimately impacts granulosa cell fate during follicle selection remains unresolved.  
Perhaps the most compelling evidence, to date, to suggest that PI3K/Akt 
signaling, rather than MAPK/ERK signaling, is most important to GC survival comes 
from studies of IGF-1 effects. Briefly, Quirk and colleagues investigated the effects of 
IGF-1 on FasL-induced apoptosis of GC in a variety of ways [105], [153], [194]. In 
particular, IGF-1 exerts a protective effect against FasL-induced apoptosis in a manner 
similar to fetal bovine serum (i.e., 10% FBS) [153]. Interestingly, EGF and basic FGF 
(also found in FBS) also provide these effects, and EGF stimulates GC proliferation more 
effectively than IGF-1 [153]. The protective effects occur through the activation of 
PI3K/Akt signaling, and results in the inactivation of pro-apoptotic molecules, BAD and 
caspase-9 [153]. However, others have found MAPK/ERK signaling has protective 
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effects, coordinating extensively with PI3K/Akt signaling, by mediating cell survival 
[185], reducing BAD expression [185], and preventing other apoptotic effects [110], 
[172].  Use of IGF binding protein-3 (IGFBP-3) restores FasL-induced cell death in 
serum-containing conditions [58], which suggests that IGF-1 alone in FBS-containing 
culture medium is responsible for the protective effect. However, IGFBP-3 modulates not 
only IGF-1-related signaling, but also the effects of TGF/Smad and EGFR signaling 
[195], which further stimulate a variety of intracellular pathways. All of these factors, 
including IGF-1, are likely components of FBS, so the conclusion that PI3/Akt activation 
alone mediates cell survival is debatable. Of note, in most of the aforementioned 
experiments, the culture medium often contained up to 5% FBS, and interferon gamma 
was used to augment FasL-induced cell killing. In the current study, bovine GCs were 
cultured using serum-free conditions, and FasL-induced apoptosis of bovine GCs in the 
absence of interferon gamma. These precautions diminish the possibility that any 
confounding growth factors, other than TGF alone, influenced the outcome of the FasL 
experiments. Nevertheless, TGF failed to prevent FasL-induced apoptosis. Observing 
that effects of TGF in bovine GCs are mediated, in part, through MAPK/ERK signaling, 
the case for such signaling offering protection against cytokine-induced cell death is 
weakened. Conversely, a compelling case can be made for the involvement of PI3K/Akt 
signaling in GC survival during follicular selection in cattle [153], [196]. Furthermore, 
inhibition of PI3K/Akt signaling stimulated by IGF-1 and TGF in chicken GCs results 
in enhanced apoptosis, whereas inhibition of MAPK/ERK stimulation by these same 
factors does not [197]. Although TGF induces phosphorylation of Akt, its actions are 
less potent than IGF-1 [197], which further supports the concept of extensive crosstalk 
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between MAPK/ERK and PI3K/Akt signaling in granulosa cells. Rather than influencing 
follicular selection, perhaps TGF is more critical to differentiation of GCs within the 
ovulatory follicle, augmenting the process of luteinization.  
Based upon the results presented here and the findings of others [111], [131], we 
now speculate that TGF is an oocyte-derived factor that induces MAPK/ERK signaling 
in bovine GCs to prepare the dominant follicle for ovulation while simultaneously 
preparing the oocyte for final maturation. In bovine GCs, EGF/TGF suppress estradiol 
production [131], [134]. In humans, other EGF ligands (amphiregulin and epiregulin) 
augment luteal steroidogenesis through activation of both ERK and Akt phosphorylation 
[198]. Further evidence supporting this role of TGFα in GC differentiation stems from 
work performed in human granulosa cells, wherein LH stimulated an upregulation of 
mRNA and protein expression of EGF family members, amphiregulin and epiregulin, and 
treatment with these factors, in turn, induced progesterone biosynthesis [198]. As the 
follicle begins to prepare to ovulate, the cumulus GCs surrounding the oocyte undergo  
rapid proliferation, with EGF stimulation of MAPK signaling being required for cumulus 
expansion [199]. MAPK signaling is similarly important for oocyte maturation [200], 
which clearly shows that connections between the oocyte and GC are mediated through 
EGF ligands. The LH-induced breakdown of gap junctions between cumulus GC and the 
oocyte triggers resumption of meiosis, and the activation of MAPK signaling is required 
for this [200].   
In conclusion, the results of the current study show that TGF is a potent 
activator of bovine GC proliferation, in which the actions of TGFα are mediated 
principally by MAPK/ERK signaling and the upregulation of phosphorylated ERK 
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expression. Despite its growth-promoting properties, TGFα failed to prevent FasL-
induced apoptosis, which casts doubt on its capacity to promote GC survival and follicle 
persistence during bovine follicular selection and deviation. An alternative role for TGFα 
is suggested, in which its actions via MAPK/ERK signaling facilitate differentiation of 
GC within the follicle as ovulation becomes imminent.  
Due to the eliminative culture methods utilized for the experiments herein, there 
are a number of experimental pitfalls which could be addressed. One such pitfall being 
that as more substances are removed from the culture media, the less likely the culture 
environment mimics the in vivo conditions from which the cells are derived. Adding to 
this, no phenotypic screening was pursued to confirm that the bovine granulosa cells in 
culture had maintained their granulosa cell-like characteristics (e.g., the ability to respond 
to FSH stimulation and produce estradiol). Because of this, the possibility remains that 
the cells luteinized over the course of the culture period. Additionally, many of the 
isolated growth factors utilized were of human origin. This problem of species-specificity 
call into question whether human-derived biomolecules and growth factors exert the 
same effects on bovine cells. It is conceivable that cow-derived growth factors with 
different sequence homologies and binding specificities differ biologically from their 
human isoforms. Any observed effects induced by the human-derived TGFα, for 
example, might not exhibit an identical biological action to that of cow-derived TGFα.  
Broader the impacts of this work could extend to feeding the world more 
sustainably, and by understanding the reproductive mechanisms of cattle more clearly, 
help to produce animal-sourced food in an economical manner. By improving our 
understanding of bovine folliculogenesis at the cellular and molecular levels, estrus 
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synchronization protocols may be further refined and applied in the context of improved 
fertility in cattle. The United Nations Food and Agriculture Organization (FAO) predicts 
that global food shortages will occur by 2050 as global human populations exceed the 
rate of sustainable food production [201]. Many countries affected by population growth 
have a growing middle class economy in which people earn more money and desire to 
purchase animal-based food sources [202]. This presents a challenge to animal 
agriculture, which has an ongoing goal to improve animal fertility in an efficient and 
sustainable manner.  
 49 
COMPREHENSIVE BIBLIOGRAPHY 
[1] J. De Alba and S. A. Asdell, “Estrous behavior and hormones in the cow.,” J. 
Comp. Psychol., vol. 39, no. 2, pp. 119–123, 1946. 
[2] R. J. McDonald, “Bovine Sterility.,” Can. J. Comp. Med. Vet. Sci., vol. 13, no. 7, 
pp. 181–9, Jul. 1949. 
[3] J. N. Wiltbank, W. J. Tyler, L. E. Casida, O. T. Fosgate, and D. G. Sprain, “A 
study of large follicles in six sire-groups of Holstein-Friesian cows,” J. Dairy Sci., 
vol. 36, pp. 1077–1082, 1953. 
[4] L. E. Casida and A. B. Cttapman, “Factors affecting the incidence of cystic ovaries 
in a herd of Holstein cows,” J. Dairy Sci., vol. 34, no. 12, pp. 1200–1205, 1951. 
[5] J. G. Hall, C. Branton, and E. J. Stone, “Estrus, estrous cycles, ovulation time, time 
of service, and fertility of dairy cattle in Louisiana,” J. Dairy Sci., vol. 42, no. 6, 
pp. 1086–1094, 1959. 
[6] S. J. Folley and F. H. Malpress, “The response of the bovine ovary to pregnant 
mares’ serum and horse pituitary extract,” Proc. R. Soc. B - Biol. Sci., vol. 132, no. 
867, pp. 164–188, 1944. 
[7] E. Rajakoski, “The ovarian follicular system in sexually mature heifers with 
special reference to seasonal, cyclical, and left-right variations,” Obstet. Gynecol. 
Surv., vol. 15, no. 6, pp. 836–838, Aug. 1960. 
[8] R. A. Pierson and O. J. Ginther, “Ultrasonography of the Bovine Ovary,” 
Theriogenology, vol. 21, no. 3, pp. 495–504, 1984. 
[9] R. A. Pierson and O. J. Ginther, “Ovarian follicular populations during early 
pregnancy in heifers,” Theriogenology, vol. 26, no. 5, pp. 649–659, Nov. 1986. 
[10] L. E. Donaldson and W. Hansel, “Cystic corpora lutea and normal and cystic 
Graafian follicles in the cow,” Aust. Vet. J., vol. 44, no. 7, pp. 304–308, Jul. 1968. 
[11] J. Priedkalns, A. F. Weber, and R. Zemjanis, “Qualitative and Quantitative 
Morphological Studies of the Cells of the Membrana Granulosa, Theca Interna and 
Corpus Luteum of the Bovine Ovary*,” Zeitschrift ffir Zellforsch., vol. 85, pp. 
501–520, 1968. 
[12] J. Sirois and J. E. Fortune, “Ovarian Follicular Dynamics during the Estrous Cycle 
in Heifers Monitored by Real-Time UItrasonography,” Biol. Reprod., vol. 39, no. 
2, pp. 308–317, Sep. 1988. 
[13] J. D. Savio, L. Keenan, M. P. Boland, and J. F. Roche, “Pattern of growth of 
dominant follicles during the oestrous cycle of heifers,” Reproduction, vol. 83, no. 
2, pp. 663–671, 1988. 
[14] O. J. Ginther, L. Knopf, and J. P. Kastelic, “Temporal associations among ovarian 
events in cattle during oestrous cycles with two and three follicular waves.,” J. 
Reprod. Fertil., vol. 87, no. 1, pp. 223–30, Sep. 1989. 
[15] O. J. Ginther, J. P. Kastelic, and L. Knopf, “Composition and Characteristics of 
Follicular Waves during the Bovine Estrous Cycle,” 1989. 
[16] L. Knopf, J. P. Kastelic, E. Schallenberger, and O. J. Ginther, “Ovarian follicular 
dynamics in heifers: Test of two-wave hypothesis by ultrasonically monitoring 
individual follicles,” Domest. Anim. Endocrinol., vol. 6, no. 2, pp. 111–119, Apr. 
1989. 
 50 
[17] N. Forde, M. E. Beltman, P. Lonergan, M. Diskin, J. F. Roche, and M. A. Crowe, 
“Oestrous cycles in Bos taurus cattle,” Anim. Reprod. Sci., vol. 124, no. 3–4, pp. 
163–169, Apr. 2011. 
[18] G. P. Adams, R. L. Matteri, and O. J. Ginther, “Effect of progesterone on ovarian 
follicles, emergence of follicular waves and circulating follicle-stimulating 
hormone in heifers,” J. Reprod. Fertil., vol. 95, no. 2, pp. 627–640, 1992. 
[19] J. F. Roche, “Control and regulation of folliculogenesis-a symposium in 
perspective,” 1996. 
[20] G. P. Adams, R. L. Matteri, J. P. Kastelic, J. C. Ko, and O. J. Ginther, 
“Association between surges of follicle-stimulating hormone and the emergence of 
follicular waves in heifers.,” J. Reprod. Fertil., vol. 94, no. 1, pp. 177–88, Jan. 
1992. 
[21] K. J. Bodensteiner, K. Kot, M. C. Wiltbank, and O. J. Ginther, “Synchronization of 
emergence of follicular waves in cattle,” Theriogenology, vol. 45, pp. 1115–1128, 
1996. 
[22] S. J. Sunderland, M. A. Crowe, M. P. Boland, J. F. Roche, and J. J. Ireland, 
“Selection, dominance and atresia of follicles during the oestrous cycle of 
heifers.,” J. Reprod. Fertil., vol. 101, no. 3, pp. 547–55, Aug. 1994. 
[23] C. A. Price and R. Webb, “Steroid Control of Gonadotropin Secretion and Ovarian 
Function in Heifers,” Endocrinology, vol. 122, no. 5, pp. 2222–2231, May 1988. 
[24] A. J. Beard, R. J. Castillo, B. J. McLeod, R. G. Glencross, and P. G. Knight, 
“Comparison of the effects of crude and highly purified bovine inhibin (Mr 32 
000) on plasma concentrations of FSH and LH in chronically ovariectomized 
prepubertal heifers,” J. Endocrinol., vol. 125, no. 1, pp. 21–30, Apr. 1990. 
[25] M. A. Beg and O. J. Ginther, “Follicle selection in cattle and horses: role of 
intrafollicular factors,” Reproduction, vol. 132, no. 3, pp. 365–77, Sep. 2006. 
[26] J. R. Gibbons, M. C. Wiltbank, and O. J. Ginther, “Functional Interrelationships 
between Follicles Greater than 4 mm and the Follicle-Stimulating Hormone Surge 
in Heifers,” Biol. Reprod., vol. 57, no. 5, pp. 1066–1073, Nov. 1997. 
[27] O. J. Ginther, K. Kot, L. J. Kulick, and M. C. Wiltbank, “Emergence and deviation 
of follicles during the development of follicular waves in cattle,” Theriogenology, 
vol. 48, no. 1, pp. 75–87, 1997. 
[28] C. Glister, D. S. Tannetta, N. P. Groome, and P. G. Knight, “Interactions Between 
Follicle-Stimulating Hormone and Growth Factors in Modulating Secretion of 
Steroids and Inhibin-Related Peptides by Nonluteinized Bovine Granulosa Cells,” 
Biol. Reprod., vol. 65, no. 4, pp. 1020–1028, Oct. 2001. 
[29] O. J. Ginther, D. R. Bergfelt, L. J. Kulick, and K. Kot, “Selection of the Dominant 
Follicle in Cattle: Role of Two-Way Functional Coupling Between Follicle-
Stimulating Hormone and the Follicles,” Biol. Reprod., vol. 62, no. 4, pp. 920–
927, Apr. 2000. 
[30] A. C. O. Evans and J. E. Fortune, “Selection of the Dominant Follicle in Cattle 
Occurs in the Absence of Differences in the Expression of Messenger Ribonucleic 
Acid for Gonadotropin Receptors,” Endocrinology, vol. 138, no. 7, pp. 2963–2971, 
Jul. 1997. 
[31] H. Kaneko, H. Kishi, G. Watanabe, K. Taya, S. Sasmoto, and Y. Hasegawa, 
 51 
“Changes in Plasma Concentrations of Immunoreactive Inhibin, Estradiol and FSH 
Associated with Follicular Waves during the Estrous Cycle of the Cow,” J. 
Reprod. Dev., vol. 41, no. 4, pp. 311–320, Jan. 1995. 
[32] B. K. Campbell et al., “Domestic ruminants as models for the elucidation of the 
mechanisms controlling ovarian follicle development in humans,” Reprod. Suppl., 
vol. 61, pp. 429–443, 2003. 
[33] D. G. Armstrong and R. Webb, “Ovarian follicular dominance: the role of 
intraovarian growth factors and novel proteins,” Rev. Reprod., vol. 2, pp. 139–146, 
1997. 
[34] C. G. Gutierrez, B. K. Campbell, and R. Webb, “Development of a Long-Term 
Bovine Granulosa Cell Culture System: Induction and Maintenance of Estradiol 
Production, Response to Follicle-Stimulating Hormone, and Morphological 
Characteristics’,” Biol. Reprod., vol. 56, pp. 608–616, 1997. 
[35] D. J. Langhout, L. J. Spicer, and R. D. Geisert, “Development of a culture system 
for bovine granulosa cells: effects of growth hormone, estradiol, and 
gonadotropins on cell proliferation, steroidogenesis, and protein synthesis.,” J. 
Anim. Sci., vol. 69, no. 8, p. 3321, 1991. 
[36] F. H. McCaffery, R. Leask, S. C. Riley, and E. E. Telfer, “Culture of Bovine 
Preantral Follicles in a Serum-Free System: Markers for Assessment of Growth 
and Development1,” Biol. Reprod., vol. 63, no. 1, pp. 267–273, Jul. 2000. 
[37] A. J. Roberts and M. K. Skinner, “Transforming Growth Factor-α and -β 
Differentially Regulate Growth and Steroidogenesis of Bovine Thecal Cells during 
Antral Follicle Development,” Endocrinology, vol. 129, no. 4, pp. 2041–2048, 
Oct. 1991. 
[38] T. S. Hussein, D. A. Froiland, F. Amato, J. G. Thompson, and R. B. Gilchrist, 
“Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine 
gradient of bone morphogenetic proteins.,” J. Cell Sci., vol. 118, no. Pt 22, pp. 
5257–68, Nov. 2005. 
[39] D. A. Porter, S. L. Vickers, R. G. Cowan, S. C. Huber, and S. M. Quirk, 
“Expression and Function of Fas Antigen Vary in Bovine Granulosa and Theca 
Cells During Ovarian Follicular Development and Atresia,” Biol. Reprod., vol. 62, 
no. 1, pp. 62–66, Jan. 2000. 
[40] G. Neufeld, N. Ferrara, L. Schweigerer, R. Mitchell, and D. Gospodarowicz, 
“Bovine Granulosa Cells Produce Basic Fibroblast Growth Factor,” 
Endocrinology, vol. 121, no. 2, pp. 597–603, Aug. 1987. 
[41] D. Gospodarowicz and H. Bialecki, “The Effects of the Epidermal and Fibroblast 
Growth Factors on the Replicative Lifespan of Cultured Bovine Granulosa 
Cells*,” Endocrinology, vol. 103, no. 3, pp. 854–865, Sep. 1978. 
[42] D. Gospodarowicz, C. R. Ill, and C. R. Birdwell, “Effects of Fibroblast and 
Epidermal Growth Factors on Ovarian Cell Proliferation in Vitro. I. 
Characterization of the Response of Granulosa Cells to FGF and EGF,” 
Endocrinology, vol. 100, no. 4, pp. 1108–1120, Apr. 1977. 
[43] M. K. Skinner, J. Keski-Oja, K. G. Osteen, and H. L. Moses, “Ovarian Thecal 
Cells Produce Transforming Growth Factor-β Which Can Regulate Granulosa Cell 
Growth*,” Endocrinology, vol. 121, no. 2, pp. 786–792, Aug. 1987. 
 52 
[44] D. K. Lobb, M. S. Kobrin, J. E. Kudlow, and J. H. Dorrington, “Transforming 
growth factor-alpha in the adult bovine ovary: identification in growing ovarian 
follicles,” Biol Reprod, vol. 40, no. 5, pp. 1087–1093, 1989. 
[45] M. K. Skinner and R. J. Coffey, “Regulation of Ovarian Cell Growth through the 
Local Production of Transforming Growth Factor-α by Theca Cells,” 
Endocrinology, vol. 123, no. 6, pp. 2632–2638, Dec. 1988. 
[46] D. W. Schomberg, J. May, and S. Mondscheln, “Interactions between hormones 
and growth factors in the regulation of granulosa cell differentiation in vitro,” 
1983. 
[47] D. K. Lobb and J. Dorrington, “Intraovarian regulation of follicular development,” 
Anim. Reprod. Sci., vol. 28, no. 1–4, pp. 343–354, Jul. 1992. 
[48] N. Savion, G.-M. Lui, R. Laharty, and D. Gospodarowicz, “Factors Controlling 
Proliferation and Progesterone Production by Bovine Granulosa Cells in Serum-
Free Medium,” Endocrinology, vol. 109, no. 2, pp. 409–420, Aug. 1981. 
[49] A. M. Mani, M. A. Fenwick, Z. Cheng, M. K. Sharma, D. Singh, and D. C. 
Wathes, “IGF1 induces up-regulation of steroidogenic and apoptotic regulatory 
genes via activation of phosphatidylinositol- dependent kinase/AKT in bovine 
granulosa cells,” Reproduction, vol. 139, pp. 139–151, 2010. 
[50] W. Hansel and S. E. Echternkamp, “Control of Ovarian Function in Domestic 
Animals,” Integr. Comp. Biol., vol. 12, no. 2, pp. 225–243, 1972. 
[51] A. V Schally et al., “Gonadotropin-releasing hormone: one polypeptide regulates 
secretion of luteinizing and follicle-stimulating hormones.,” Science, vol. 173, no. 
4001, pp. 1036–8, Sep. 1971. 
[52] S. J. Crowe, Cushing Harvey, and J. Homans, “Experimental Hypophysectomy,” 
Baltimore, 1910. 
[53] B. Lunenfeld, “Historical perspectives in gonadotrophin therapy,” Hum. Reprod. 
Update, vol. 10, no. 6, pp. 453–467, Dec. 2004. 
[54] B. Zondek, “Weitere Untersuchungen zur Darstellung, Biologie und Klinik des 
Hypophysenvorderlappenhormones (Prolan),” Zentralbl. Gynakol., vol. 14, pp. 
834–848, 1929. 
[55] R. W. Bates, O. Riddle, and E. L. Lahr, “An assay of three hormones present in 
anterior pituitaries of seven types of cattle classified for age and stage of 
reproduction,” Am. J. Psychol., vol. 113, no. 2, pp. 259–264, 1935. 
[56] W. Dobrowolski, Elżbieta Stupnicka, and E. Domański, “Progesterone levels in 
ovarian venous blood during the osetrous cycle of the cow,” J. Reprod. Fertil., vol. 
15, no. 3, pp. 409–414, 1968. 
[57] D. M. Henricks, J. F. Dickey, and J. R. Hill, “Plasma Estrogen and Progesterone 
Levels in Cows Prior to and During Estrus,” Endocrinology, vol. 89, no. 6, pp. 
1350–1355, 1971. 
[58] G. V. Groom, “The measurement of human gonadotropins by radioimmunoassay,” 
Reproduction, vol. 51, no. 1, pp. 273–286, 1977. 
[59] O. J. Ginther and D. R. Bergfelt, “Associations between FSH concentrations and 
major and minor follicular waves in pregnant mares,” Theriogenology, vol. 38, pp. 
807–821, 1992. 
[60] O. J. Ginther, D. R. Bergfelt, M. A. Beg, and K. Kot, “Role of low circulating FSH 
 53 
concentrations in controlling the interval to emergence of the subsequent follicular 
wave in cattle.,” Reproduction, vol. 124, no. 4, pp. 475–82, Oct. 2002. 
[61] D. Monniaux et al., “Regulation of anti-Müllerian hormone production in domestic 
animals,” Reprod. Fertil. Dev., vol. 25, no. 1, p. 1, Dec. 2013. 
[62] C. Rico et al., “Anti-Mullerian Hormone Is an Endocrine Marker of Ovarian 
Gonadotropin-Responsive Follicles and Can Help to Predict Superovulatory 
Responses in the Cow,” Biol. Reprod., vol. 80, no. 1, pp. 50–59, Jan. 2009. 
[63] J. L. H. Ireland et al., “Antral Follicle Count Reliably Predicts Number of 
Morphologically Healthy Oocytes and Follicles in Ovaries of Young Adult 
Cattle1,” Biol. Reprod., vol. 79, no. 6, pp. 1219–1225, Dec. 2008. 
[64] S. . Wandji, J. J. Eppig, and J. E. Fotune, “FSH and growth factors affect the 
growth and endocrine function of granulosa cells of bovine preantral follicles,” 
Theriogenology, vol. 45, pp. 817–832, 1996. 
[65] H. A. Garverick et al., “Regulation of expression of ovarian mRNA encoding 
steroidogenic enzymes and gonadotrophin receptors by FSH and GH in 
hypogonadotrophic cattle.,” Reproduction, vol. 123, no. 5, pp. 651–61, May 2002. 
[66] J. K. Findlay and A. E. Drummond, “Regulation of the FSH Receptor in the 
Ovary,” Trends Endocrinol. Metab., vol. 10, no. 5, pp. 183–188, Jul. 1999. 
[67] S. G. Hillier, “Current concepts of the roles of follicle stimulating hormone and 
luteinizing hormone in folliculogenesis,” Hum. Reprod., vol. 9, no. 2, pp. 188–191, 
Feb. 1994. 
[68] J. K. Findlay, “An Update on the Roles of Inhibin, Activin, and Follistatin as Local 
Regulators of Folliculogenesis’,” 1993. 
[69] J. E. Fortune, “Bovine Theca and Granulosa Cells Interact to Promote Androgen 
Production,” Biol. Reprod., vol. 35, pp. 292–299, 1986. 
[70] K. P. McNatty et al., “Some aspects of thecal and granulosa cell function during 
follicular development in the bovine ovary,” J. Reprod. Fertil., vol. 72, no. 1, pp. 
39–53, 1984. 
[71] J. M. Young and A. S. McNeilly, “Theca: the forgotten cell of the ovarian 
follicle,” Reproduction, vol. 140, no. 4, pp. 489–504, 2010. 
[72] J. E. Fortune and S. M. Quirk, “Regulation of steroidogenesis in bovine 
preovulatory follicles,” J. Anim. Sci., vol. 66, no. suppl_2, pp. 1–8, Jan. 1988. 
[73] O. Ginther, M. C. Wiltbank, P. M. Fricke, J. Gibbons, and K. Kot, “Selection of 
the dominant follicle in cattle,” Biol. Reprod., vol. 55, pp. 1187–1194, 1997. 
[74] O. J. Ginther, D. R. Bergfelt, M. A. Beg, and K. Kot, “Follicle Selection in Cattle: 
Role of Luteinizing Hormone,” Biol. Reprod., vol. 64, no. 1, pp. 197–205, Jan. 
2001. 
[75] O. J. Ginther, M. A. Beg, D. R. Bergfelt, F. X. Donadeu, and K. Kot, “Follicle 
Selection in Monovular Species,” 2001. 
[76] D. Schams, E. Schallenberger, B. Hoffmann, and H. Karg, “The oestrous cycle of 
the cow: hormonal parameters and time relationships concerning oestrus, 
ovulation, and electrical resistance of the vaginal mucus,” Eur. J. Endocrinol., vol. 
86, no. 1, pp. 180–192, Sep. 1977. 
[77] R. P. Wettemann, H. D. Hafs, L. A. Edgerton, and L. V. Swanson, “Estradiol and 
Progesterone in Blood Serum during the Bovine Estrous Cycle,” J. Anim. Sci., vol. 
 54 
34, no. 6, pp. 1020–1024, Jun. 1972. 
[78] T. W. Beck and E. M. Convey, “Estradiol Control of Serum Luteinizing Hormone 
Concentrations in the Bovine,” J. Anim. Sci., vol. 45, no. 5, pp. 1096–1101, Nov. 
1977. 
[79] K. M. Henderson and Y. S. Moon, “Luteinization of bovine granulosa cells and 
corpus luteum formation associated with loss of androgen-aromatizing ability,” J. 
Reprod. Fertil., vol. 56, pp. 89–97, 1979. 
[80] R. Meidan, E. Girsh, O. Blum, and E. Aberdam, “In Vitro Differentiation of 
Bovine Theca and Granulosa Cells into Small and Large Luteal-like Cells: 
Morphological and Functional Characteristics,” Biol. Reprod., vol. 43, no. 6, pp. 
913–921, Dec. 1990. 
[81] M. D. Calder, B. E. Salfen, B. Bao, R. S. Youngquist, and H. A. Garverick, 
“Administration of progesterone to cows with ovarian follicular cysts results in a 
reduction in mean LH and LH pulse frequency and initiates ovulatory follicular 
growth.,” J. Anim. Sci., vol. 77, no. 11, p. 3037, Nov. 1999. 
[82] J. S. Davis, L. L. Weakland, D. A. Weiland, R. V Farese, L. A. West, and J. A. 
Haley, “Prostaglandin F2a stimulates phosphatidylinositol 4,5-bisphosphate 
hydrolysis and mobilizes intracellular Ca2+; in bovine luteal cells,” 1987. 
[83] A. Miyamoto and K. Shirasuna, “Luteolysis in the cow: a novel concept of 
vasoactive molecules,” Anim. Reprod., vol. 6, no. 1, pp. 47–59, 2009. 
[84] C. H. Knight, “Lactation and gestation in dairy cows: flexibility avoids nutritional 
extremes,” Proc. Nutr. Soc., vol. 60, no. 04, pp. 527–537, Nov. 2001. 
[85] C. R. Staples, W. W. Thatcher, and J. H. Clark, “Relationship Between Ovarian 
Activity and Energy Status During the Early Postpartum Period of High Producing 
Dairy Cows,” J. Dairy Sci., vol. 73, pp. 938–947, 1990. 
[86] F. Montiel and C. Ahuja, “Body condition and suckling as factors influencing the 
duration of postpartum anestrus in cattle: a review,” Anim. Reprod. Sci., vol. 85, 
pp. 1–26, 2003. 
[87] A. T. Peter, P. L. A. M. Vos, and D. J. Ambrose, “Postpartum anestrus in dairy 
cattle,” Theriogenology, vol. 71, pp. 1333–1342, 2009. 
[88] M. C. Lucy, “Reproductive Loss in High-Producing Dairy Cattle: Where Will It 
End?,” American Dairy Science Association, 2001. 
[89] M. O. M. J. R. Pursley  M. C. Wiltbank, “Synchronization of Ovulation in Dairy 
Cows using PGF2a and GnRH,” Theriogenology, no. 44, pp. 915–923, 1995. 
[90] R. L. Nebel and S. M. Jobst, “Evaluation of Systematic Breeding Programs for 
Lactating Dairy Cows: A Review,” J. Dairy Sci., vol. 81, pp. 1169–1174, 1998. 
[91] R. J. Rodgers, H. F. Rodgers, P. F. Hall, M. R. Waterman, and E. R. Simpson, 
“Immunolocalization of cholesterol side-chain-cleavage cytochrome P-450 and 
17α-hydroxylase cytochrome P-450 in bovine ovarian follicles,” J. Reprod. Fertil., 
vol. 78, pp. 627–638, 1986. 
[92] J. Y. Jiang, G. Macchiarelli, B. K. Tsang, and E. Sato, “Capillary angiogenesis and 
degeneration in bovine ovarian antral follicles,” 2003. 
[93] O. Yamada, M. Abe, K. Takehana, T. Hiraga, K. Iwasa, and T. Hiratsuka, 
“Microvascular changes during the development of follicles in bovine ovaries: a 
study of corrosion casts by scanning electron microscopy.,” Arch. Histol. Cytol., 
 55 
vol. 58, no. 5, pp. 567–74, Dec. 1995. 
[94] R. J. Rodgers and H. F. Irving-Rodgers, “Formation of the Ovarian Follicular 
Antrum and Follicular Fluid,” Biol. Reprod., vol. 82, no. 6, pp. 1021–1029, Jun. 
2010. 
[95] M. K. Skinner, E. E. Nilsson, and R. K. Bhandari, “Cell–Cell Signaling in the 
Testis and Ovary,” in Handbook of Cell Signaling, Elsevier, 2010, pp. 2663–2678. 
[96] A. Ben-Chetrit, L. Gotlieb, P. Y. Wong, and R. F. Casper, “Ovarian response to 
recombinant human follicle-stimulating hormone in luteinizing hormone-depleted 
women: examination of the two cell, two gonadotropin theory,” Fertil. Steril., vol. 
65, no. 4, pp. 711–717, Apr. 1996. 
[97] Y.-X. Liu and A. J. W. Hsueh, “Synergism between Granulosa and Theca-
Interstitial Cells in Estrogen Biosynthesis by Gonadotropin-Treated Rat Ovaries: 
Studies on the Two-Cell, Two-Gonadotropin Hypothesis Using Steroid Antisera,” 
Biol. Reprod., vol. 35, no. 1, pp. 27–36, Aug. 1986. 
[98] T. Fair, S. C. J. Hulshof, P. Hyttel, T. Greve, and M. Boland, “Oocyte 
ultrastructure in bovine primordial to early tertiary follicles,” Anat. Embryol. 
(Berl)., vol. 195, pp. 327–336, 1997. 
[99] R. J. Rodgers and H. Irving-Rodgers, “Morphological classification of bovine 
ovarian follicles,” Reproduction, vol. 139, pp. 309–318, 2010. 
[100] W. Hansel, H. W. Ali, J. P. Dowd, and X. Yang, “Control of Steroidogenesis in 
Small and Large Bovine Luteal. Cells*,” Aust. J. Biol. Sci., vol. 40, no. 3, pp. 331–
378, 1987. 
[101] E. Y. Adashi, C. E. Resnick, A. J. D’ercole, M. E. Svoboda, and J. J. VAN Wyk, 
“Insulin-Like Growth Factors as Intraovarian Regulators of Granulosa Cell 
Growth and Function,” Endocr. Rev., vol. 6, no. 3, pp. 400–420, Jul. 1985. 
[102] D. Monniaux and C. Pisselet, “Control of Proliferation and Differentiation of 
Ovine Granulosa Cells by Insulin-like Growth Factor-I and Follicle-Stimulating 
Hormone in Vitro,” Biol. Reprod., vol. 46, no. 1, pp. 109–119, Jan. 1992. 
[103] L. J. Spicer, C. S. Chamberlain, and S. M. Maciel, “Influence of gonadotropins on 
insulin-and insulin-like growth factor-I (IGF-I)-induced steroid production by 
bovine granulosa cells,” Domest. Anim. Endocrinol., vol. 22, no. 22, pp. 237–254, 
2002. 
[104] M. Párrizas, A. R. Saltiel, and D. LeRoith, “Insulin-like growth factor 1 inhibits 
apoptosis using the phosphatidylinositol 3’-kinase and mitogen-activated protein 
kinase pathways.,” J. Biol. Chem., vol. 272, no. 1, pp. 154–61, Jan. 1997. 
[105] C.-L. Hu, R. G. Cowan, R. M. Harman, and S. M. Quirk, “Cell Cycle Progression 
and Activation of Akt Kinase Are Required for Insulin-Like Growth Factor I-
Mediated Suppression of Apoptosis in Granulosa Cells,” Mol. Endocrinol., vol. 18, 
no. 2, pp. 326–338, Feb. 2004. 
[106] J. V. May, J. P. Frost, and D. W. Schomberg, “Differential Effects of Epidermal 
Growth Factor, Somatomedin-C/Insulin-Like Growth Factor I, and Transforming 
Growth Factor-β on Porcine Granulosa Cell Deoxyribonucleic Acid Synthesis and 
Cell Proliferation,” Endocrinology, vol. 123, no. 1, pp. 168–179, Jul. 1988. 
[107] S. C. Baumgarten, M. Armouti, C. Ko, and C. Stocco, “IGF1R Expression in 
Ovarian Granulosa Cells Is Essential for Steroidogenesis, Follicle Survival, and 
 56 
Fertility in Female Mice,” Endocrinology, vol. 158, no. 7, pp. 2309–2318, Jul. 
2017. 
[108] K. E. Ryan, S. M. Casey, M. J. Canty, M. A. Crowe, F. Martin, and A. C. O. 
Evans, “Akt and Erk signal transduction pathways are early markers of 
differentiation in dominant and subordinate ovarian follicles in cattle.,” 
Reproduction, vol. 133, no. 3, pp. 617–26, Mar. 2007. 
[109] K. E. Ryan, C. Glister, P. Lonergan, F. Martin, P. G. Knight, and A. C. Evans, 
“Functional significance of the signal transduction pathways Akt and Erk in 
ovarian follicles: in vitro and in vivo studies in cattle and sheep,” J. Ovarian Res., 
vol. 1, no. 1, p. 2, Oct. 2008. 
[110] G. Gebauer, A. T. Peter, D. Onesime, and N. Dhanasekaran, “Apoptosis of ovarian 
granulosa cells: Correlation with the reduced activity of ERK-signaling module,” 
J. Cell. Biochem., vol. 75, no. 4, pp. 547–554, Dec. 1999. 
[111] M. Conti, M. Hsieh, J.-Y. Park, and Y.-Q. Su, “Role of the Epidermal Growth 
Factor Network in Ovarian Follicles,” Mol. Endocrinol., vol. 20, no. 4, pp. 715–
723, Apr. 2006. 
[112] H. Billig, A. Tsafriri, A. J. W. Hsueh, and H. Billig, “Ovarian Follicle Atresia: A 
Hormonally Controlled Apoptotic Process*,” Endocr. Rev., vol. 15, no. 6, pp. 707–
724, 1994. 
[113] R. Ross and A. Vogel, “The platelet-derived growth factor,” Cell, vol. 14, no. 2, 
pp. 203–210, Jun. 1978. 
[114] R. A. Bradshaw and H. D. Niall, “Insulin-related growth factors,” Trends Biochem. 
Sci., vol. 3, no. 4, pp. 274–278, Oct. 1978. 
[115] K. L. Jones, D. Gospodarowicz, and  hmuniced J. by Edwin Seegmiller, 
“Biological Activity of a Growth Factor for Ovarian Cells,” 1974. 
[116] D. Gospodarowicz, G. Greenburg, H. Bialecki, and B. R. Zetter, “Factors involved 
in the modulation of cell proliferation in vivo and in virto: the role of fibroblast 
and epidermal growth factors in the proliferative response of mammalian cells,” In 
Vitro, vol. 14, no. 1, pp. 85–118, 1978. 
[117] G. D. Plowman et al., “Ligand-specifi’c activation of HER4/pl80erbB4, a fourth 
member of the epidermal growth factor receptor family (receptor tyrosine 
kne/ERBB4 gene product),” 1993. 
[118] M. R. Schneider and E. Wolf, “The epidermal growth factor receptor ligands at a 
glance,” J. Cell. Physiol., vol. 218, no. 3, pp. 460–466, Mar. 2009. 
[119] L. A. Bazley and W. J. Gullick, “The epidermal growth factor receptor family,” 
Endocr. Relat. Cancer, vol. 12, no. Supplement_1, pp. S17–S27, Jul. 2005. 
[120] M. A. Lemmon and J. Schlessinger, “Cell Signaling by Receptor Tyrosine 
Kinases,” Cell, vol. 141, 2010. 
[121] A. Ullrich and J. Schlessinger, “Signal Transduction by Receptors with Tyrosine 
Kinase Activity,” 1990. 
[122] J. Schlessinger, “Cell Signaling by Receptor Tyrosine Kinases,” 2000. 
[123] I. Vlodavsky, K. D. Brown, and D. Gospodarowicz, “A Comparison of the 
Binding of Epidermal Growth Factor to Cultured Granulosa and Luteal Cells*,” J. 
Biol. Chem., vol. 253, pp. 3744–3750, 1978. 
[124] C.-J. Hsu, S. D. Holmes, and J. M. Hammond, “Ovarian epidermal growth factor-
 57 
like activity. Concentrations in porcine follicular fluid during follicular 
enlargement,” Biochem. Biophys. Res. Commun., vol. 147, no. 1, pp. 242–247, 
Aug. 1987. 
[125] J. E. De Larco and G. J. Todaro, “Growth factors from murine sarcoma virus-
transformed cells.,” Proc. Natl. Acad. Sci. U. S. A., vol. 75, no. 8, pp. 4001–5, 
Aug. 1978. 
[126] D. R. Twardzik, G. J. Todaro, F. H. Reynolds, and J. R. Stephenson, “Similar 
Transforming Growth Factors (TGFs) Produced by Cells Transformed by 
Different Isolates of Feline Sarcoma Virus,” 1983. 
[127] Massague and J., “Epidermal growth factor-like transforming growth factor,” J. 
Biol. Chem., vol. 258, pp. 13606–13613, 1983. 
[128] J. V. May and D. W. Schomberg, “The Potential Relevance of Epidermal Growth 
Factor and Transforming Growth Factor-Alpha to Ovarian Physiology,” Semin. 
Reprod. Endocrinol., vol. 7, no. 1, 1989. 
[129] E. Y. Adashi and C. E. Resnick, “Antagonistic interactions of tranforming growth 
factors in the regulation of granulosa cell differentiation,” Endocrinology, vol. 119, 
no. 4, pp. 1879–1881, Oct. 1986. 
[130] J. J. Bendell and J. Dorrington, “Rat Thecal/Interstitial Cells Secrete a 
Transforming Growth Factor-β-Like Factor that Promotes Growth and 
Differentiation in Rat Granulosa Cells,” Endocrinology, vol. 123, no. 2, pp. 941–
948, Aug. 1988. 
[131] C. Glister, N. P. Groome, and P. G. Knight, “Oocyte-Mediated Suppression of 
Follicle-Stimulating Hormone- and Insulin-Like Growth Factor-Induced Secretion 
of Steroids and Inhibin-Related Proteins by Bovine Granulosa Cells In Vitro: 
Possible Role of Transforming Growth Factor α,” Biol. Reprod., vol. 68, no. 3, pp. 
758–765, Mar. 2003. 
[132] J. L. Tilly, H. Billig, K. I. Kowalski, and A. J. Hsueh, “Epidermal growth factor 
and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in 
cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent 
mechanism.,” Mol. Endocrinol., vol. 6, no. 11, pp. 1942–1950, Nov. 1992. 
[133] D. K. Lobb and J. H. Dorrington, “Bovine Thecal Cells Secrete Transforming 
Growth Factor α and β,” in Growth Factors and the Ovary, Boston, MA: Springer 
US, 1989, pp. 199–203. 
[134] P. Rouillier, M.-A. Sirard, P. Matton, and L. A. Guilbault, “Immunoneutralization 
of Transforming Growth Factor α Present in Bovine Follicular Fluid Prevents the 
Suppression of the Follicle-Stimulating Hormone-Induced Production of Estradiol 
by Bovine Granulosa Cells Cultured in Vitro,” Biol. Reprod., vol. 57, no. 2, pp. 
341–346, Aug. 1997. 
[135] K. Kobayashi, S. Yamashita, and H. Hoshi, “Influence of epidermal growth factor 
and transforming growth factor-α on in vitro maturation of cumulus cell-enclosed 
bovine oocytes in a defined medium,” Reproduction, vol. 100, no. 2, pp. 439–446, 
1994. 
[136] P. G. Knight and C. Glister, “Potential local regulatory functions of inhibins, 
activins, and follistatin in the ovary,” Reproduction, vol. 121, pp. 503–512, 2001. 
[137] J. F. R. Kerr, A. H. Wyllie, and A. R. Curriet, “Apoptosis: A Basic Biological 
 58 
Phenomenon with Wideranging Implications in Tissue Kinetics,” Br. J. Cance, 
vol. 26, p. 239, 1972. 
[138] A. Palumbo and J. Yeh, “Apoptosis as a Basic Mechanism in the Ovarian Cycle: 
Folicular Atresia and Luteal Regression,” J. Soc. Gynecol. Investig., vol. 2, no. 3, 
pp. 565–573, May 1995. 
[139] M. Hay, D. G. Cran, and R. M. Moor, “Structural changes occurring during atresia 
in sheep ovarian follicles,” Cell Tissue Res., vol. 169, no. 4, pp. 515–529, Jul. 
1976. 
[140] J. D. O’Shea, M. F. Hay, and D. G. Cran, “Ultrastructural changes in the theca 
interna during follicular atresia in sheep,” J. Reprod. Fertil., vol. 54, pp. 183–187, 
1978. 
[141] J. L. Tilly, K. I. Kowalski, A. L. Johnson, and A. J. W. Hsueh, “Involvement of 
apoptosis in ovarian follicular atresia and postovulatory regression,” 
Endocrinology, vol. 129, no. 5, pp. 2799–2801, Nov. 1991. 
[142] G. N. Piquette, J. L. Tilly, L. E. Prichard, C. Simón, and M. L. Polan, “Detection 
of Apoptosis in Human and Rat Ovarian Follicles,” J. Soc. Gynecol. Investig., vol. 
1, no. 4, pp. 297–301, 1994. 
[143] H. Billig, I. Furuta, and A. J. W. Hsueh, “Estrogens inhibit and androgens enhance 
ovarian granulosa cell apoptosis,” Endocrinology1, vol. 133, no. 5, pp. 2204–2212, 
1993. 
[144] A. Kaipia, S.-Y. Chun, K. Eisenhauer, and A. J. W. Hsueh, “Tumor Necrosis 
Factor-a and Its Second Messenger, Ceramide, Stimulate Apoptosis in Cultured 
Ovarian Follicles,” Endocrinology, vol. 137, no. 11, pp. 4864–4870, 1996. 
[145] P. Santana et al., “Ceramide mediates tumor necrosis factor effects on P450-
aromatase activity in cultured granulosa cells.,” Endocrinology, vol. 136, no. 5, pp. 
2345–2348, May 1995. 
[146] A. Kaipia and A. J. W. Hsueh, “Regulation of ovarian follicle atresia,” 1997. 
[147] T. Suda, T. Takahashi, P. Golstein, and S. Nagata’, “Molecular Cloning and 
Expression of the Fas Ligand, a Novel Member of the Tumor Necrosis Factor 
Family,” 1993. 
[148] R. Watanabe-Fukunaga et al., “The cDNA structure, expression, and chromosomal 
assignment of the mouse Fas antigen.,” J. Immunol., vol. 148, no. 4, pp. 1274–9, 
Feb. 1992. 
[149] S. Nagata and P. Golstein, “The Fas death factor,” Science (80-. )., vol. 1449–
1456, no. 5203, p. 677, 1995. 
[150] S. L. Vickers, R. G. Cowan, R. M. Harman, D. A. Porter, and S. M. Quirk, 
“Expression and Activity of the Fas Antigen in Bovine Ovarian Follicle Cells,” 
Biol. Reprod., vol. 62, no. 1, pp. 54–61, Jan. 2000. 
[151] J. T. Bridgham and A. L. Johnson, “Expression and Regulation of Fas Antigen and 
Tumor Necrosis Factor Receptor Type I in Hen Granulosa Cells,” Biol. Reprod., 
vol. 65, pp. 733–739, 2001. 
[152] C.-L. Hu, R. G. Cowan, R. M. Harman, D. A. Porter, and S. M. Quirk, “Apoptosis 
of Bovine Granulosa Cells After Serum Withdrawal Is Mediated by Fas Antigen 
(CD95) and Fas Ligand,” Biol. Reprod., vol. 64, no. 2, pp. 518–526, Feb. 2001. 
[153] S. M. Quirk, R. M. Harman, and R. G. Cowan, “Regulation of Fas Antigen (Fas, 
 59 
CD95)-Mediated Apoptosis of Bovine Granulosa Cells by Serum and Growth 
Factors,” Biol. Reprod., vol. 63, no. 5, pp. 1278–1284, Nov. 2000. 
[154] N. Hakuno et al., “Fas/APO-l/CD95 System as a Mediator of Granulosa Cell 
Apoptosis in Ovarian Follicle Atresia*,” Endocrinology, vol. 137, no. 5, pp. 1938–
1948, 1996. 
[155] J. Van Der Valk et al., “The humane collection of fetal bovine serum and 
possibilities for serum-free cell and tissue culture.” 
[156] C. G. Gutierrez, J. H. Ralph, E. E. Telfer, I. Wilmut, and R. Webb, “Growth and 
Antrum Formation of Bovine Preantral Follicles in Long-Term Culture In Vitro,” 
Biol. Reprod., vol. 62, pp. 1322–1328, 2000. 
[157] C. Wang et al., “Transforming Growth Factor Alpha (TGFα) Regulates Granulosa 
Cell Tumor (GCT) Cell Proliferation and Migration through Activation of Multiple 
Pathways,” PLoS One, vol. 7, no. 11, p. e48299, Nov. 2012. 
[158] S. M. Quirk, G. J. Hickey, and J. E. Fortune, “Growth and regression of ovarian 
follicles during the follicular phase of the oestrous cycle in heifers undergoing 
spontaneous and PGF-2a-induced luteolysis,” J. Reprod. Fertil., vol. 77, pp. 211–
219, 1986. 
[159] R. Webb and B. K. Campbell, “Development of the dominant follicle: mechanisms 
of selection and maintenance of oocyte quality.,” Soc. Reprod. Fertil. Suppl., vol. 
64, pp. 141–63, 2007. 
[160] H. Yada, K. Hosokawa, K. Tajima, Y. Hasegawa, and F. Kotsuji, “Role of Ovarian 
Theca and Granulosa Cell Interaction in Hormone Production and Cell Growth 
During the Bovine Follicular Maturation Process,” Biol. Reprod., vol. 61, no. 6, 
pp. 1480–1486, Dec. 1999. 
[161] R. J. Scaramuzzi A et al., “Regulation of folliculogenesis and the determination of 
ovulation rate in ruminants,” Reprod. Fertil. Dev., vol. 23, pp. 444–467, 2011. 
[162] M. l. Hennet and C. M. H. Combelles, “The antral follicle: a microenvironment for 
oocyte differentiation,” Int. J. Dev. Biol., vol. 56, no. 10-11–12, pp. 819–831, Jan. 
2012. 
[163] R. Webb, J. Buratini, J. H. Hernandez-Medrano, C. G. Gutierrez, and B. K. 
Campbell, “Follicle development and selection: past, present and future,” Anim. 
Reprod, vol. 13, no. 3, pp. 234–249, 2016. 
[164] J. R. V. Silva, J. R. Figueiredo, and R. van den Hurk, “Involvement of growth 
hormone (GH) and insulin-like growth factor (IGF) system in ovarian 
folliculogenesis,” Theriogenology, vol. 71, no. 8, pp. 1193–1208, May 2009. 
[165] M. Jamnongjit, A. Gill, S. R. Hammes, and J. D. Wilson, “Epidermal growth 
factor receptor signaling is required for normal ovarian steroidogenesis and oocyte 
maturation,” 2005. 
[166] H. Ashkenazi, X. Cao, S. Motola, M. Popliker, M. Conti, and A. Tsafriri, 
“Epidermal Growth Factor Family Members: Endogenous Mediators of the 
Ovulatory Response,” Endocrinology, vol. 146, no. 1, pp. 77–84, Jan. 2005. 
[167] E. Nilsson, J. A. Parrott, and M. K. Skinner, “Basic fibroblast growth factor 
induces primordial follicle development and initiates folliculogenesis,” Mol. Cell. 
Endocrinol., vol. 175, no. 1–2, pp. 123–130, Apr. 2001. 
[168] P. G. Knight and C. Glister, “TGF-beta superfamily members and ovarian follicle 
 60 
development.,” Reproduction, vol. 132, no. 2, pp. 191–206, Aug. 2006. 
[169] A. C.-K. Tse and W. Ge, “Spatial localization of EGF family ligands and receptors 
in the zebrafish ovarian follicle and their expression profiles during 
folliculogenesis,” Gen. Comp. Endocrinol., vol. 167, no. 3, pp. 397–407, Jul. 2010. 
[170] G. M. Andrade et al., “The role of the PI3K-Akt signaling pathway in the 
developmental competence of bovine oocytes,” PLoS One, vol. 12, no. 9, Sep. 
2017. 
[171] A. C. O. Evans and F. Martin, “Kinase pathways in dominant and subordinate 
ovarian follicles during the first wave of follicular development in sheep,” Anim. 
Reprod. Sci., vol. 64, pp. 221–231, 2000. 
[172] M. Shiota et al., “Correlation of Mitogen-Activated Protein Kinase Activities with 
Cell Survival and Apoptosis in Porcine Granulosa Cells,” Zoolog. Sci., vol. 20, pp. 
193–201, 2003. 
[173] J.-C. Cheng, H.-M. Chang, L. Fang, Y.-P. Sun, and P. C. K. Leung, “TGF-β1 Up-
Regulates Connective Tissue Growth Factor Expression in Human Granulosa Cells 
through Smad and ERK1/2 Signaling Pathways,” PLoS One, vol. 10, no. 5, p. 
e0126532, May 2015. 
[174] J. D. Yoon, S.-U. Hwang, E. Kim, M. Jin, S. Kim, and S.-H. Hyun, “GDF8 
activates p38 MAPK signaling during porcine oocyte maturation in vitro,” 
Theriogenology, vol. 101, pp. 123–134, 2017. 
[175] L. J. Spicer, P. Y. Aad, D. Allen, S. Mazerbourg, and A. J. Hsueh, “Growth 
differentiation factor-9 has divergent effects on proliferation and steroidogenesis 
of bovine granulosa cells,” J. Endocrinol., vol. 189, no. 2, pp. 329–339, May 2006. 
[176] İ. M. Polat et al., “Characterization of transforming growth factor beta 
superfamily, growth factors, transcriptional factors, and lipopolysaccharide in 
bovine cystic ovarian follicles,” Theriogenology, vol. 84, no. 6, pp. 1043–1052, 
Oct. 2015. 
[177] F. C. de Castro, M. H. C. Cruz, and C. L. V. Leal, “The Role of Growth Factors 
Growth Differentiation Factor 9 and Bone Morphogenetic Protein 15 in Ovarian 
Function and Their Importance in Mammalian Female Fertility,” Asian-
Australasian J. Anim. Sci., vol. 29, no. 8, p. 1065, 2016. 
[178] A. Sanfins, P. Rodrigues, and D. F. Albertini, “GDF-9 and BMP-15 direct the 
follicle symphony,” J. Assist. Reprod. Genet., vol. 35, no. 10, pp. 1741–1750, Oct. 
2018. 
[179] M. M. Matzuk, K. H. Burns, M. M. Viveiros, and J. J. Eppig, “Intracellular 
Communication in the Mammalian Ovary: Oocytes Carry the Conversation,” 
Science (80-. )., vol. 296, no. 5576, pp. 2178–2180, 2002. 
[180] Y. Yarden and M. X. Sliwkowski, “Untangling the ErbB Signaling Network,” Nat. 
Rev. Mol. Cell Biol., vol. 2, pp. 127–137, 2001. 
[181] M. R. Cameron, J. S. Foster, A. Bukovsky, and J. Wimalasena2, “Activation of 
Mitogen-Activated Protein Kinases by Gonadotropins and Cyclic Adenosine 5’-
Monophosphates in Porcine Granulosa Cells’,” 1996. 
[182] S. Das, E. T. Maizels, D. DeManno, E. St Clair, S. A. Adam, and M. Hunzicker-
Dunn, “A stimulatory role of cyclic adenosine 3’,5’-monophosphate in follicle- 
stimulating hormone-activated mitogen-activated protein kinase signaling pathway 
 61 
in rat ovarian granulosa cells,” Endocrinology, vol. 137, no. 3, pp. 967–974, Mar. 
1996. 
[183] B. K. Gangrade, J. S. Davis, and J. V. May, “A Novel Mechanism for the 
Induction of Aromatase in Ovarian Cells in Vitro: Role of Transforming Growth 
Factor Alpha-induced Protein Tyrosine Kinase,” Endocrinology, vol. 129, no. 5, 
pp. 2790–2792, Nov. 1991. 
[184] T. Pehlivan, A. Mansour, R. Z. Spaczynski, and A. J. Duleba, “Effects of 
transforming growth factors-alpha and -beta on proliferation and apoptosis of rat 
theca-interstitial cells,” 2001. 
[185] M. C. Mendoza, E. Emrah Er, and J. Blenis, “The Ras-ERK and PI3K-mTOR 
Pathways: Cross-talk and Compensation,” Trends Biochem. Sci., vol. 36, no. 6, pp. 
320–328, 2011. 
[186] B. A. Ballif and J. Blenis, “Molecular Mechanisms Mediating Mammalian 
Mitogen-activated Protein Kinase (MAPK) Kinase (MEK)-MAPK Cell Survival 
Signals,” Cell Growth Differ., vol. 12, pp. 397–408, 2001. 
[187] Y. Wang, J. Li, C. Ying Wang, A. H. Yan Kwok, and F. C. Leung, “Epidermal 
Growth Factor (EGF) Receptor Ligands in the Chicken Ovary: I. Evidence for 
Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Potential Oocyte-
Derived Signal to Control Granulosa Cell Proliferation and HB-EGF and Kit 
Ligand Expression,” Endocrinology, vol. 148, no. 7, pp. 3426–3440, Jul. 2007. 
[188] J. R. . Silva et al., “Influences of FSH and EGF on primordial follicles during in 
vitro culture of caprine ovarian cortical tissue,” Theriogenology, vol. 61, no. 9, pp. 
1691–1704, Jun. 2004. 
[189] T. Maruo et al., “Expression of epidermal growth factor and its receptor in the 
human ovary during follicular growth and regression,” Endocrinology, vol. 132, 
no. 2, pp. 924–931, Feb. 1993. 
[190] J. K. Nyholt De Prada, Y. S. Lee, K. E. Latham, C. L. Chaffin, and C. A. 
Vandevoort, “Role for cumulus cell-produced EGF-like ligands during primate 
oocyte maturation in vitro,” Am J Physiol Endocrinol Metab, vol. 296, pp. 1049–
1058, 2009. 
[191] Y. Wang and W. Ge, “Cloning of Epidermal Growth Factor (EGF) and EGF 
Receptor from the Zebrafish Ovary: Evidence for EGF as a Potential Paracrine 
Factor from the Oocyte to Regulate Activin/Follistatin System in the Follicle 
Cells1,” Biol. Reprod., vol. 71, no. 3, pp. 749–760, Sep. 2004. 
[192] A. Peter and N. Dhanasekaran, “Apoptosis of Granulosa Cells: A Review on the 
Role of MAPK-signalling modules,” Reprod. Domest. Anim., vol. 38, no. 3, pp. 
209–213, Jun. 2003. 
[193] P. J. . Stork and J. M. Schmitt, “Crosstalk between cAMP and MAP kinase 
signaling in the regulation of cell proliferation,” Trends Cell Biol., vol. 12, no. 6, 
pp. 258–266, Jun. 2002. 
[194] S. M. Quirk, R. G. Cowan, and R. M. Harman, “The susceptibility of granulosa 
cells to apoptosis is influenced by oestradiol and the cell cycle.,” J. Endocrinol., 
vol. 189, no. 3, pp. 441–53, Jun. 2006. 
[195] R. C. Baxter, “Insulin-like growth factor binding protein-3 (IGFBP-3): Novel 
ligands mediate unexpected functions.,” J. Cell Commun. Signal., vol. 7, no. 3, pp. 
 62 
179–89, Aug. 2013. 
[196] S. M. Quirk, R. G. Cowan, R. M. Harman, C.-L. Hu, and D. A. Porter, “Ovarian 
follicular growth and atresia: The relationship between cell proliferation and 
survival,” J. Anim. Sci., vol. 82, pp. 40–52, 2004. 
[197] A. L. Johnson, J. T. Bridgham, and J. A. Swenson, “Activation of the Akt/Protein 
Kinase B Signaling Pathway Is Associated with Granulosa Cell Survival,” Biol. 
Reprod., vol. 64, no. 5, pp. 1566–1574, May 2001. 
[198] I. Ben-Ami, L. Armon, S. Freimann, D. Strassburger, R. Ron-El, and A. 
Amsterdam, “EGF-like growth factors as LH mediators in the human corpus 
luteum,” Hum. Reprod., vol. 24, no. 1, pp. 176–184, 2009. 
[199] F. J. Diaz, K. Wigglesworth, and J. J. Eppig, “Oocytes are required for the 
preantral granulosa cell to cumulus cell transition in mice,” Dev. Biol., vol. 305, 
no. 1, pp. 300–311, May 2007. 
[200] S. Sela-Abramovich, E. Chorev, D. Galiani, and N. Dekel, “Mitogen-Activated 
Protein Kinase Mediates Luteinizing Hormone-Induced Breakdown of 
Communication and Oocyte Maturation in Rat Ovarian Follicles,” Endocrinology, 
vol. 146, no. 3, pp. 1236–1244, 2005. 
[201] P. Conforti, “Looking ahead in world food and agriculture: perspectives to 2050.,” 
Look. ahead world food Agric. Perspect. to 2050., 2011. 
[202] Fao, The future of food and agriculture: Trends and challenges. . 
 
 
 
